<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">EXCLI J</journal-id><journal-id journal-id-type="iso-abbrev">EXCLI J</journal-id><journal-id journal-id-type="pmc-domain-id">2730</journal-id><journal-id journal-id-type="pmc-domain">exclij</journal-id><journal-id journal-id-type="publisher-id">EXCLI J</journal-id><journal-title-group><journal-title>EXCLI Journal</journal-title></journal-title-group><issn pub-type="epub">1611-2156</issn><publisher><publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11382301</article-id><article-id pub-id-type="pmcid-ver">PMC11382301.1</article-id><article-id pub-id-type="pmcaid">11382301</article-id><article-id pub-id-type="pmcaiid">11382301</article-id><article-id pub-id-type="pmid">39253534</article-id><article-id pub-id-type="doi">10.17179/excli2024-7475</article-id><article-id pub-id-type="publisher-id">2024-7475</article-id><article-id pub-id-type="publisher-id">Doc991</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Deciphering NF-kappaB pathways in smoking-related lung carcinogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Thapa</surname><given-names initials="R">Riya</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moglad</surname><given-names initials="E">Ehssan</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Goyal</surname><given-names initials="A">Ahsas</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bhat</surname><given-names initials="AA">Asif Ahmad</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Almalki</surname><given-names initials="WH">Waleed Hassan</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kazmi</surname><given-names initials="I">Imran</given-names></name><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alzarea</surname><given-names initials="SI">Sami I.</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ali</surname><given-names initials="H">Haider</given-names></name><xref rid="A7" ref-type="aff">7</xref><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oliver</surname><given-names initials="BG">Brian Gregory</given-names></name><xref rid="A9" ref-type="aff">9</xref><xref rid="A10" ref-type="aff">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacLoughlin</surname><given-names initials="R">Ronan</given-names></name><xref rid="A11" ref-type="aff">11</xref><xref rid="A12" ref-type="aff">12</xref><xref rid="A13" ref-type="aff">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dureja</surname><given-names initials="H">Harish</given-names></name><xref rid="A14" ref-type="aff">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Singh</surname><given-names initials="SK">Sachin Kumar</given-names></name><xref rid="A15" ref-type="aff">15</xref><xref rid="A16" ref-type="aff">16</xref><xref rid="A17" ref-type="aff">17</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dua</surname><given-names initials="K">Kamal</given-names></name><xref rid="COR1" ref-type="corresp">*</xref><xref rid="A16" ref-type="aff">16</xref><xref rid="A18" ref-type="aff">18</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gupta</surname><given-names initials="G">Gaurav</given-names></name><xref rid="A19" ref-type="aff">19</xref><xref rid="A20" ref-type="aff">20</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India</aff><aff id="A2">
<label>2</label>Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia</aff><aff id="A3">
<label>3</label>Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India</aff><aff id="A4">
<label>4</label>Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia</aff><aff id="A5">
<label>5</label>Department of Biochemistry, Faculty of Science, King Abdulaziz University, 21589, Jeddah, Saudi Arabia</aff><aff id="A6">
<label>6</label>Department of Pharmacology, College of Pharmacy, Jouf University, 72341, Sakaka, Al-Jouf, Saudi Arabia</aff><aff id="A7">
<label>7</label>Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India</aff><aff id="A8">
<label>8</label>Department of Pharmacology, Kyrgyz State Medical College, Bishkek, Kyrgyzstan</aff><aff id="A9">
<label>9</label>Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW 2137 Australia</aff><aff id="A10">
<label>10</label>School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007 Australia</aff><aff id="A11">
<label>11</label>Research and Development, Aerogen Limited, IDA Business Park, Galway, Connacht, H91 HE94 Ireland</aff><aff id="A12">
<label>12</label>School of Pharmacy &amp; Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Leinster, D02 YN77 Ireland</aff><aff id="A13">
<label>13</label>School of Pharmacy &amp; Pharmaceutical Sciences, Trinity College, Dublin, Leinster, D02 PN40 Ireland</aff><aff id="A14">
<label>14</label>Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, 124001, Haryana, India</aff><aff id="A15">
<label>15</label>School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India</aff><aff id="A16">
<label>16</label>Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, Australia</aff><aff id="A17">
<label>17</label>School of Medical and Life Sciences, Sunway University, Sunway City, 47500, Malaysia</aff><aff id="A18">
<label>18</label>Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia</aff><aff id="A19">
<label>19</label>Center for Research Impact &amp; Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab</aff><aff id="A20">
<label>20</label>Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Kamal Dua, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia, E-mail: <email>kamalpharmacist02@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>8</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">455545</issue-id><fpage>991</fpage><lpage>1017</lpage><history><date date-type="received"><day>05</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>01</day><month>7</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>09</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-10 17:25:40.467"><day>10</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2024 Thapa et al.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="EXCLI-23-991.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.excli.de/vol23/excli2024-7475.pdf">This article is available from https://www.excli.de/vol23/excli2024-7475.pdf</self-uri><abstract><p>One of the main causes of death worldwide is lung cancer, which is largely caused by cigarette smoking. The crucial transcription factor NF-&#954;B, which controls inflammatory responses and various cellular processes, is a constitutively present cytoplasmic protein strictly regulated by inhibitors like I&#954;B proteins. Upon activation by external stimuli, it undergoes phosphorylation, translocates into the nucleus, and modulates the expression of specific genes. The incontrovertible association between pulmonary malignancy and tobacco consumption underscores and highlights a public health concern. Polycyclic aromatic hydrocarbons and nitrosamines, potent carcinogenic compounds present in the aerosol emitted from combusted tobacco, elicit profound deleterious effects upon inhalation, resulting in severe perturbation of pulmonary tissue integrity. The pathogenesis of smoking-induced lung cancer encompasses an intricate process wherein NF-&#954;B activation plays a pivotal role, triggered by exposure to cigarette smoke through diverse signaling pathways, including those associated with oxidative stress and pro-inflammatory cytokines. Unraveling the participation of NF-&#954;B in smoking-induced lung cancer provides pivotal insights into molecular processes, wherein intricate crosstalk between NF-&#954;B and pathways such as MAPK and PI3K-Akt amplifies the inflammatory response, fostering an environment conducive to the formation of lung cancer. This study reviews the critical function of NF-&#954;B in the complex molecular pathways linked to the initiation and advancement of lung carcinogenesis as well as potential treatment targets.</p><p>See also the graphical abstract<xref rid="F1" ref-type="fig">(Fig. 1)</xref>.</p></abstract><kwd-group><kwd>smoking</kwd><kwd>lung cancer</kwd><kwd>NF-kappaB pathway</kwd><kwd>tumorigenesis</kwd><kwd>inflammation</kwd><kwd>therapeutic interventions</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Lung cancer is a major cause of mortality worldwide and a major public health problem. The main cause of lung cancer, accounting for around 85 % of instances, is tobacco use, which includes using cigarettes, cigars, and pipes (de Sousa and Carvalho, 2018[<xref rid="R46" ref-type="bibr">46</xref>]). Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two most prevalent kinds of lung cancer; NSCLC is more common and develops more slowly, whilst SCLC is less common but frequently grows more swiftly (Dubin and Griffin, 2020[<xref rid="R55" ref-type="bibr">55</xref>]). Even with significant advancements in tobacco control, lung cancer will continue to be a leading cause of death globally for a number more decades, given present smoking habits (Hirsch et al., 2017[<xref rid="R82" ref-type="bibr">82</xref>]). Lung cancer is predicted to have killed 1.8 million people in 2020 (18 %) (Hoy et al., 2019[<xref rid="R87" ref-type="bibr">87</xref>]). Air pollution, asbestos and chemical exposure at work, and secondhand smoke are additional risk factors for lung cancer (Huang et al., 2023[<xref rid="R90" ref-type="bibr">90</xref>]). Early lung cancer symptoms might be insignificant or mistaken for other respiratory problems, delaying detection (Abubakar et al., 2023[<xref rid="R1" ref-type="bibr">1</xref>]; Chang et al., 2021[<xref rid="R31" ref-type="bibr">31</xref>]). Lung cancer caused by smoking is still one of the biggest worldwide health concerns and because of its significant effects on general health, it is imperative to fully understand the underlying molecular pathways of this disease (Dela Cruz et al., 2011[<xref rid="R48" ref-type="bibr">48</xref>]; Hou et al., 2019[<xref rid="R86" ref-type="bibr">86</xref>]). Lung cancer caused by smoking is one of the world's most common causes of cancer-related fatalities, and most instances are associated with cigarette smoking (Lee and Kazerooni, 2022[<xref rid="R113" ref-type="bibr">113</xref>]). The substances found in smoke from cigarettes can damage the genetic material in the lung cells, placing you at a considerably elevated risk of getting lung cancer (Balaga et al., 2023[<xref rid="R11" ref-type="bibr">11</xref>]; Malyla et al., 2023[<xref rid="R132" ref-type="bibr">132</xref>]). Even with significant advancements in tobacco control, lung cancer will continue to be a leading cause of death globally for a number more decades, given present smoking habits.</p><sec><title>Global impact of lung cancer and its association with smoking</title><p>The enormous worldwide burden of lung cancer is a reflection of both the disease's variety and the ubiquitous effect of tobacco use (Nagah and Amer, 2021[<xref rid="R142" ref-type="bibr">142</xref>]). According to the World Health Organization (WHO), lung cancer accounts for around 2.1 million new cases and 1.8 million deaths worldwide each year, making up almost half of the cancer burden (Nagah et al., 2019[<xref rid="R143" ref-type="bibr">143</xref>]). Smoking is identified as the primary causative cause of lung cancer development due to its wide range of carcinogenic chemicals (Priji&#263; and Igi&#263;, 2021[<xref rid="R153" ref-type="bibr">153</xref>]). About 85 % of cases of lung cancer are caused by smoking, which is the main avoidable risk factor for the illness. The regional distribution of lung cancer incidence is closely connected with variations in smoking prevalence among regions (Rivera and Wakelee, 2016[<xref rid="R164" ref-type="bibr">164</xref>]). The relationship between smoking and lung cancer is further shown by the fact that countries with greater tobacco use rates also tend to have higher incidences of lung cancer (Saba et al., 2017[<xref rid="R167" ref-type="bibr">167</xref>]). It is critical to comprehend this global context because it emphasizes the pressing need for comprehensive initiatives to reduce the incidence and death of lung cancer caused by smoking (Shreves et al., 2023[<xref rid="R171" ref-type="bibr">171</xref>]; Wang et al., 2021[<xref rid="R193" ref-type="bibr">193</xref>]).</p></sec><sec><title>NF-&#954;B's role in the pathogenesis of smoking-induced lung cancer</title><p>The NF-&#954;B transcription factor family is necessary for several physiological processes, such as cell survival, immune responses, and proliferation (Aswini, 2009[<xref rid="R8" ref-type="bibr">8</xref>]). Its involvement in cancer has been well investigated; findings indicate that dysregulation of it happens in several malignancies, including lung cancer (Chiang et al., 2023[<xref rid="R37" ref-type="bibr">37</xref>]). Despite its context-dependent participation in cancer and potential pro- and anti-tumorigenic properties, the precise roles played by NF-&#954;B in smoking-induced lung cancer remain an intriguing and challenging area of investigation (Conlon et al., 2020[<xref rid="R39" ref-type="bibr">39</xref>]; Czy&#380;ykowski et al., 2016). Cigarette smoke contains a complex mixture of over 7,000 chemicals, which causes lung tissues to go through a sequence of reactions that lead to DNA damage, chronic inflammation, and cancer (Bao et al., 2023[<xref rid="R12" ref-type="bibr">12</xref>]). One important chemical event that is brought on by these events is NF-&#954;B activation. Nevertheless, further research is necessary to determine the exact pathways by which NF-&#954;B affects the development and course of smoking-induced lung cancer (Chiang et al., 2023[<xref rid="R37" ref-type="bibr">37</xref>]; Conlon et al., 2020[<xref rid="R39" ref-type="bibr">39</xref>]). The complicated etiology of smoking-related lung cancer includes the interplay of inherited, environmental, and lifestyle factors (Jin et al., 2021[<xref rid="R94" ref-type="bibr">94</xref>]). A number of carcinogens, including polycyclic aromatic hydrocarbons (PAHs), nitrosamines, and heavy metals, are present in cigarette smoke. These chemicals damage DNA, induce mutations, and alter epigenetic patterns, all of which promote the growth of cancer (Bhat et al., 2024[<xref rid="R18" ref-type="bibr">18</xref>]; Jomova et al., 2023[<xref rid="R97" ref-type="bibr">97</xref>]). Cigarette smoke not only causes genotoxicity but also chronic inflammation, which creates an environment that is conducive to the growth of cancer (Li et al., 2019[<xref rid="R119" ref-type="bibr">119</xref>]). The recruitment of immune cells is facilitated by inflammatory mediators such as chemokines and cytokines, which intensify the inflammatory response (Lin et al., 2021[<xref rid="R122" ref-type="bibr">122</xref>]). An important role for NF-&#954;B, a master regulator of inflammation, appears in this process (Ma et al., 2020[<xref rid="R129" ref-type="bibr">129</xref>]). Because of its adaptability in cellular functions, NF-&#954;B is an important participant in the intricate web of processes that are set off by exposure to cigarette smoke (Qian et al., 2022[<xref rid="R155" ref-type="bibr">155</xref>]). Comprehending the ways in which NF-&#954;B influences inflammation, immunological response, and cell survival in the context of smoking-induced lung cancer is essential for the creation of focused therapeutic approaches (Bhat et al., 2023[<xref rid="R19" ref-type="bibr">19</xref>]; Qiu et al., 2017[<xref rid="R156" ref-type="bibr">156</xref>]). This review attempts to critically evaluate the molecular processes that NF-&#954;B orchestrates in the pathogenesis of smoking-induced lung cancer, address current developments in lung cancer therapy and prevention.</p></sec></sec><sec><title>NF-&#954;B: An Overview</title><p>An essential modulator of cellular responses, NF-&#954;B affects a wide range of physiological functions. In the realm of cancer, NF-&#954;B is a an essential molecular conductor that directs complex signaling cascades that advance the illness (Williams and Gilmore, 2020[<xref rid="R197" ref-type="bibr">197</xref>]; Zhang et al., 2017[<xref rid="R207" ref-type="bibr">207</xref>]). When it functions properly, NF-&#954;B is essential for immunological responses, inflammation, and cell viability (Wibisana and Okada, 2022[<xref rid="R196" ref-type="bibr">196</xref>]). On the other hand, smoking-related lung cancer is one type of cancer linked to abnormal NF-&#954;B activation (Bhat et al., 2023[<xref rid="R20" ref-type="bibr">20</xref>]; Sun, 2011[<xref rid="R178" ref-type="bibr">178</xref>]). Understanding the complex involvement of NF-&#954;B in cellular dynamics provides a crucial foundation for understanding the complexities of smoking-induced lung cancer and opens up new avenues for targeted therapeutics intended to disrupt the cascade of events orchestrated by this molecular player.</p><sec><title>NF-&#954;B's involvement in cancer</title><p>In an environment of cancer, NF-&#954;B plays a dual role as an adversary and a protector at the junction of cellular destiny (DiDonato et al., 2012[<xref rid="R50" ref-type="bibr">50</xref>]). As a guardian of cellular survival, NF-&#954;B orchestrates immune responses and maintains tissue homeostasis when it is operating appropriately (Eluard et al., 2020[<xref rid="R58" ref-type="bibr">58</xref>]). On the other hand, NF-&#954;B becomes a potent cancer-spread promoter when it is activated improperly (Fan et al., 2013[<xref rid="R60" ref-type="bibr">60</xref>]). NF-&#954;B performs a myriad of functions in the complicated topography of cancer. It increases chronic inflammation, promotes cell proliferation, and inhibits apoptosis, all of which help to create an environment that is conducive to tumor growth (Hoesel and Schmid, 2013[<xref rid="R84" ref-type="bibr">84</xref>]; Khan et al., 2020[<xref rid="R101" ref-type="bibr">101</xref>]). When smoking causes lung cancer, the carcinogenic components of tobacco smoke become the crucial factor that triggers NF-&#954;B activation (Bhat et al., 2024[<xref rid="R21" ref-type="bibr">21</xref>]; Lalle et al., 2021[<xref rid="R111" ref-type="bibr">111</xref>]). Lung cancer develops, advances, and is maintained by a number of molecular pathways that are triggered and maintained by this activation (Lawrence, 2011[<xref rid="R112" ref-type="bibr">112</xref>]).</p></sec><sec><title>NF-&#954;B activation in response to smoking-induced inflammation</title><p>It is known that inhaling tobacco smoke triggers the transcription factor NF-&#954;B, which is essential for inflammation (Conlon et al., 2020[<xref rid="R39" ref-type="bibr">39</xref>]). In one study, gingival epithelial cells (Ca9-22) were treated to 10 % cigarette smoke extract (CSE) for six hours (Dang et al., 2020[<xref rid="R43" ref-type="bibr">43</xref>]). The results showed that the RAGE was significantly more expressed, and this caused the NF-&#954;B signaling pathways to be activated (Deng et al., 2023[<xref rid="R49" ref-type="bibr">49</xref>]). Via quantitative PCR and immunoblotting, the enhanced RAGE expression following CSE therapy was confirmed. Moreover, the activation of Ras and additional NF-&#954;B signaling intermediates was observed (Gon&#231;alves et al., 2011[<xref rid="R68" ref-type="bibr">68</xref>]). The previously stated activation suggests that NF-&#954;B is necessary for the cell's response to inflammation brought on by smoking (He et al., 2020[<xref rid="R76" ref-type="bibr">76</xref>]). Further evidence that NF-&#954;B is active in the inflammatory cascade comes from the study's evaluation of larger levels of pro-inflammatory cytokines, such as IL-1&#946; and IL-6 in the cell culture media of CSE-exposed cells than in controls (Hirano, 2021[<xref rid="R80" ref-type="bibr">80</xref>]; Huang et al., 2022[<xref rid="R91" ref-type="bibr">91</xref>]). Co-treatment with CSE and SAGEs effectively decreased the inflammatory responses, indicating the involvement of NF-&#954;B in smoking-induced inflammation. These findings demonstrate the involvement of NF-&#954;B in the molecular pathways of inflammation caused by cigarette smoke, offering insights that might aid in the development of focused therapies for oral conditions exacerbated by tobacco smoke exposure (Kunnumakkara et al., 2020[<xref rid="R110" ref-type="bibr">110</xref>]; Rastrick et al., 2013[<xref rid="R160" ref-type="bibr">160</xref>]) (Figure 2<xref rid="F2" ref-type="fig">(Fig. 2)</xref>).</p></sec></sec><sec><title>Mechanisms of NF-&#954;B Activation in Smoking-Induced Lung Cancer</title><sec><title>MARCKS pathway</title><p>Lung cancer caused by smoking is largely influenced by NF-&#954;B. The transcription factor NF-&#954;B, which controls the expression of genes linked to cell division, survival, and inflammation, is activated by prolonged inhalation of tobacco smoke (Rojas-Quintero et al., 2023[<xref rid="R166" ref-type="bibr">166</xref>]). A number of processes are triggered by this activation, which contributes to the tumor's development and dissemination (Sivandzade et al., 2019[<xref rid="R174" ref-type="bibr">174</xref>]). NF-&#954;B promotes angiogenesis, prevents apoptosis, and helps cancer cells survive (Sokolova and Naumann, 2017[<xref rid="R175" ref-type="bibr">175</xref>]). Moreover, it sets off the production of cytokines that promote inflammation, creating an environment that is conducive to the growth of tumors (Thapa et al., 2022[<xref rid="R187" ref-type="bibr">187</xref>]; Walter et al., 2020[<xref rid="R190" ref-type="bibr">190</xref>]). Targeting NF-&#954;B signaling pathways presents a promising avenue for therapeutic therapies in smoking-associated lung cancer by interfering with critical processes that promote oncogenesis and progression (Bhat et al., 2024[<xref rid="R22" ref-type="bibr">22</xref>]; Wang et al., 2019[<xref rid="R191" ref-type="bibr">191</xref>]). Cellular signaling and cytoskeletal regulation are mediated by a protein known as MARCKS (Wei et al., 2022[<xref rid="R195" ref-type="bibr">195</xref>]). It is necessary for a number of biological processes, including as cell motility, membrane trafficking, and exocytosis (Wronka et al., 2022[<xref rid="R198" ref-type="bibr">198</xref>]). Numerous physiological and pathological processes in cells are impacted by MARCKS's interaction with cell membranes, which is influenced by its level of phosphorylation (Li et al., 2019[<xref rid="R119" ref-type="bibr">119</xref>]). Liu et al. examined the function of MARCKS in lung cancer caused by smoking. It was discovered that smoking cigarettes activates MARCKS in lung cancer cells and the epithelium of the airways. The NF-&#954;B signaling is activated as a result of this activation, and low survival and phospho-NF-&#954;B are strongly associated. On the other hand, EMT, pro-inflammatory cytokines, and stem-like characteristics are all upregulated by phospho-MARCKS. These effects are suppressed when MPS peptide is used to target MARCKS phosphorylation (Liu et al., 2021[<xref rid="R123" ref-type="bibr">123</xref>]) (Figure 3<xref rid="F3" ref-type="fig">(Fig. 3)</xref>).</p></sec><sec><title>Cell surface receptor-mediated pathways</title><p>The cell surface receptor for IGF-1 is IGF-1R. It relates to the family of receptor tyrosine kinases and is crucial for cellular growth, differentiation, and survival (Bhalla et al., 2022[<xref rid="R17" ref-type="bibr">17</xref>]; Geffken et al., 2022[<xref rid="R66" ref-type="bibr">66</xref>]). IGF-1R activation sets off a signaling cascade that controls a volume of cellular functions and aids in the growth and upkeep of tissues (Hellstrom et al., 2017[<xref rid="R77" ref-type="bibr">77</xref>]). IGF-1R signaling dysregulation has been linked to cancer and other illnesses (Higashi et al., 2019[<xref rid="R78" ref-type="bibr">78</xref>]). According to the study by Min et al., smoking-related lung carcinogenesis is connected with the activation of RTKs. The study revealed that this process requires NNK-induced activation of the &#946;-AR, which in turn promotes the IGF-1R. NNK administration activated the IGF-1R signaling pathway, which was blocked by pharmacologic or genetic suppression of &#946;-AR. &#946;-AR and NF-&#954;B agonists were shown to increase IGF-1R phosphorylation, and treating mice with &#946;-AR antagonists prevented the development of lung cancers. In order to help smokers, avoid lung cancer, the research suggests that blocking &#946;-AR-mediated IGF-1R activation might be an effective strategy (Min et al., 2016[<xref rid="R139" ref-type="bibr">139</xref>]). Tpl2 kinase is a serine-threonine kinase that is involved in inflammatory and immunological responses (Esc&#243;s et al., 2022[<xref rid="R59" ref-type="bibr">59</xref>]). It is sometimes referred to as Cot kinase. It has a role in MAP kinase pathway activation (Bhat et al., 2023[<xref rid="R23" ref-type="bibr">23</xref>]; Johannessen et al., 2010[<xref rid="R96" ref-type="bibr">96</xref>]). A study by Sun et al. discovered that NF-&#954;B actually has a tumor-suppressive effect. Low patient survival and elevated exposure to cancer of the lungs in people are associated with NF-&#954;B1 downregulation. NF-&#954;B1-deficient mice, however, are more susceptible to lung carcinogenesis brought on by urethane, a smoking carcinogen. Instead of acting as an NF-&#954;B factor, as is the case with its traditional role, NF-&#954;B1 suppresses tumors via stabilizing Tpl2 kinase. When it comes to lung carcinogenesis triggered by urethane, Tpl2-knockout animals are similar to NF-&#954;B1 knockouts. The study revealed unidentified role for p105/ Tpl2 signaling in lung homeostasis and an unexpected, NF-&#954;B-independent but Tpl2-dependent role for NF-&#954;B1 in suppressing lung tumors (Sun et al., 2016[<xref rid="R177" ref-type="bibr">177</xref>]). </p><p>One cell surface receptor connected to inflammatory reactions is the RAGE (Krizan and Johar, 2015[<xref rid="R108" ref-type="bibr">108</xref>]). Cigarette smoke exposure raises the expression of RAGE, which exacerbates oral inflammation (Leone et al., 2021[<xref rid="R115" ref-type="bibr">115</xref>]). It was investigated if semi-synthetic glycosaminoglycan ethers (SAGEs) could suppress RAGE signaling. In gingival epithelial cells, co-treatment with SAGEs and cigarette smoke extract reduced inflammatory responses (MacLaren, 2015[<xref rid="R130" ref-type="bibr">130</xref>]). This implies that SAGEs could be useful in reducing the effects of RAGE-mediated inflammation, offering a possible path for therapeutic treatments in illnesses made worse by exposure to tobacco smoke (Rasmussen, 2015[<xref rid="R159" ref-type="bibr">159</xref>]). Sanders et al. examined that exposing gingival Ca9-22 to 10 % CSE for six hours increased RAGE expression and activated NF-&#954;B and Ras signaling. Elevated IL-6 and IL-1&#946; in the culture medium indicated inflammatory responses. SAGEs were used to block RAGE signaling, reducing inflammatory effects when co-treated with CSE. This suggests a potential therapeutic target in NF-&#954;B-related pathways for diseases exacerbated by tobacco smoke-induced oral inflammation (Sanders et al., 2017[<xref rid="R168" ref-type="bibr">168</xref>]).</p></sec><sec><title>Genetic variants and polymorphisms</title><p>Genetic variants in the NF-&#954;B1 gene, which codes for a subunit of the NF-&#954;B transcription factor, are referred to as NF-&#954;B1 polymorphisms (Aidinidou et al., 2021[<xref rid="R3" ref-type="bibr">3</xref>]). These differences may impact NF-&#954;B activity, which in turn may impact inflammation and the immune system (Bhat et al., 2023[<xref rid="R23" ref-type="bibr">23</xref>]; Cartwright et al., 2016[<xref rid="R30" ref-type="bibr">30</xref>]). Among other diseases, certain SNPs have been connected to a higher chance of developing autoimmune and inflammatory disorders (Jin et al., 2019[<xref rid="R95" ref-type="bibr">95</xref>]). Yin et al. studied five different forms of NF-&#954;B1, which were investigated in relation to smoking and other genes in research that included 387 Chinese controls that were cancer-free, whereas 384 patients had lung cancer. Although individual variations did not directly correlate with the risk of lung cancer, a particular haplotype did indicate a lower risk when smoking duration was taken into account. The results emphasize the importance of NF-&#954;B and smoking in inflammation-associated lung cancer etiology and point to a possible link between NF-&#954;B1 polymorphisms, smoking duration, and lung cancer development in the Chinese population (Yin et al., 2015[<xref rid="R203" ref-type="bibr">203</xref>]). </p><p>The study by Lu et al. on the effects of CSE on HBE cells also showed that CSE decreased PTEN levels while increasing the expression of miR-21, p-Akt, p-NF-&#954;B and HIF-1&#945;. Suppression of PTEN caused by increased miR-21 has an effect on the Akt/NF-&#954;B pathway. Silencing of HIF-1&#945; or NF-&#954;B prevented CSE-induced alterations, whereas miR-21 up-regulation reversed these effects. The results uncover a new pathway that connects smoking, miR-21, HIF-1&#945;, and NF-&#954;B to lung carcinogenesis brought on by CSE (Lu et al., 2018[<xref rid="R126" ref-type="bibr">126</xref>]). Using a squamous cancer cell line as a comparison, Rohrer et al. examined the effect of CSC on NF-&#954;B activation in HPV-transformed oral and bronchial cells. NF-&#954;B was activated in a dose-dependent manner by all cells, while HPV-transformed cells responded more strongly. Smoking cigarettes may accelerate the NF-&#954;B-dependent development of HPV+ premalignancy into cancer. The findings propose that future research should concentrate on NF-&#954;B targeting during premalignancy and malignant development, especially in HPV+ individuals (Rohrer et al., 2010[<xref rid="R165" ref-type="bibr">165</xref>]).</p><p>While the NF-&#954;B1 rs28362491 polymorphism is linked to altered NF-&#954;B activity, a crucial regulator of inflammation and immunological responses, the PPP1R13L gene produces a protein implicated in apoptosis (Chen et al., 2016[<xref rid="R34" ref-type="bibr">34</xref>]; Guo et al., 2021[<xref rid="R71" ref-type="bibr">71</xref>]). Genetic differences in NF-&#954;B1 may impact NF-&#954;B-mediated activities, which in turn may affect susceptibility to certain illnesses (Li and Zhang, 2019[<xref rid="R118" ref-type="bibr">118</xref>]). Comprehending these genetic variables offers valuable perspectives on the intricate relationship between genetic alterations and cellular processes in both well-being and illness (Long et al., 2022[<xref rid="R125" ref-type="bibr">125</xref>]). Yin et al. evaluate the relationship between smoking duration, PPP1R13L, NF-&#954;B1 rs28362491 polymorphism, and lung cancer risk in a Chinese population. After examining 544 instances of lung cancer and 550 age, sex, and ethnicity-matched controls, NF-&#954;B1 rs28362491 was not associated with the risk of developing lung cancer. A higher risk was seen in the dominant model for CD3EAP rs967591. Lung cancer was linked to a common haplotype comprising CD3EAP rs967591(A), PPP1R13L rs1970764(G), and CD3EAP rs735482(C). The results of interaction studies demonstrated associations between the length of smoking and NF-&#954;B1 rs28362491-PPP1R13L rs1970764 as well as CD3EAP rs735482, indicating participation in the same pathway that results in smoking-induced lung cancer (Yin et al., 2016[<xref rid="R202" ref-type="bibr">202</xref>]). </p></sec><sec><title>Interaction with nicotine and NNK</title><p>Cigarette Smoke Extract (CSE) is produced when cigarette smoke condenses, it is made up of a complicated mixture of substances, such as tar, nicotine, and several hazardous compounds (Cai et al., 2021[<xref rid="R29" ref-type="bibr">29</xref>]). In order to imitate the effects of cigarette smoke exposure on biological systems, researchers frequently utilize CSE in their studies (Fang et al., 2021[<xref rid="R61" ref-type="bibr">61</xref>]). This helps to identify possible therapies for smoke-induced health concerns as well as insights into the processes behind smoking-related disorders (Gellner et al., 2016[<xref rid="R67" ref-type="bibr">67</xref>]). Zhao et al. examined the effects of CSE on HBE cells, with particular attention to the transition between the epithelium and mesenchymal tissue (EMT) and inflammation. Exposure to CSE for an extended period of time resulted in EMT and cellular transformation, which in turn activated NF-&#954;B and increased proinflammatory interleukin-6 (IL-6). As a result, miR-200c levels dropped. Suppressing miR-200c and boosting EMT, NF-&#954;B and IL-6 pathways were shown to be involved in CSE-induced IL-6 elevation. The maintenance of the change produced by CSE required IL-6. The prevention of CSE-induced EMT and malignant transformation was achieved by NF-&#954;B inhibition, revealing a connection between inflammation, EMT, and CSE-induced lung carcinogenesis (Hussain et al., 2023[<xref rid="R92" ref-type="bibr">92</xref>]; Zhao et al., 2013[<xref rid="R209" ref-type="bibr">209</xref>]). </p><p>Nicotine is a stimulant that affects the central nervous system and is extremely addictive (Bitzer et al., 2023[<xref rid="R25" ref-type="bibr">25</xref>]; Brown et al., 2003[<xref rid="R28" ref-type="bibr">28</xref>]). Tobacco smoke contains NNK, a powerful carcinogen (Ding et al., 2008[<xref rid="R52" ref-type="bibr">52</xref>]). The body activates NNK metabolically, which damages DNA and promotes the growth of certain malignancies, including lung cancer (Edwards et al., 2021[<xref rid="R56" ref-type="bibr">56</xref>]). The negative health consequences of tobacco usage are mostly caused by both nicotine and NNK (Gankhuyag et al., 2017[<xref rid="R64" ref-type="bibr">64</xref>]; Singla et al., 2023[<xref rid="R173" ref-type="bibr">173</xref>]). Tsurutani et al. examined the effects of nicotine and NNK, two tobacco constituents, on the survival and proliferation of lung cancer cells via triggering the Akt pathway. In both SCLC and NSCLC cells, nicotine and NNK quickly activated Akt. FKHR, GSK-3, mTOR, tuberin, and S6K1 were among the downstream substrates whose phosphorylation was elevated by nicotine. Different nicotinic acetylcholine receptor subunits were expressed by NSCLC cells. Akt was activated by nicotine via the alpha3/alpha4 or alpha7 subunits. In an Akt-dependent and NF-&#954;B-dependent way, nicotine-induced proliferation and prevented apoptosis, pointing to a possible connection between smoking and the advancement of cancer (Tsurutani et al., 2005[<xref rid="R188" ref-type="bibr">188</xref>]). Similarly, Sugano et al. looked at how nicotine affected the inflammatory mediators that activated macrophages generated. Before LPS treatment, nicotine dramatically reduced the transcriptional levels of PGE2, IL-1, and IL-8 in U937 cells. The decrease of NF-&#954;B, a transcription factor essential for activating these genes, was connected to the inhibition. These results imply that nicotine's inhibition of NF-&#954;B may be a factor in the immunosuppression brought on by cigarette smoke (Sugano et al., 1998[<xref rid="R176" ref-type="bibr">176</xref>]).</p><p>A type of cigarette called light cigarettes (LC) is made to emit less tar and nicotine when smoked (Benowitz et al., 2017[<xref rid="R15" ref-type="bibr">15</xref>]). For this, manufacturers employ filters, modified tobacco mixes, or a combination of the two (Breitbarth et al., 2018[<xref rid="R27" ref-type="bibr">27</xref>]). Even though they are referred to be "light," smokers may make up for lower nicotine levels by taking larger puffs or smoking more cigarettes, so they are not always a safer option (Chang et al., 2021[<xref rid="R31" ref-type="bibr">31</xref>]; Thapa et al., 2024[<xref rid="R180" ref-type="bibr">180</xref>]). There are still health concerns, and regulations have been put in place to clear up misunderstandings about how little harm they actually cause (Crosbie et al., 2022[<xref rid="R40" ref-type="bibr">40</xref>]). Valenca et al. show that exposure to light cigarettes (LC) is thought to carry less health hazards than conventional cigarettes; nonetheless, research conducted on C57BL/6 mice showed negative consequences after 60 days of exposure to 3, 6, or 12 LC. Emphysema, an imbalance in ECM, a reduction in tissue inhibitor of metalloprotease-2, and an increase in matrix metalloprotease-12 detection were seen in the 12 LC group. Despite thoughts of less danger, the study indicates that LC may really be harmful to the lungs, altering the balance of the extracellular matrix and exacerbating emphysema. In comparison to mice exposed to ambient air, higher levels of NF-&#954;B and TNF-alpha were also seen in the LC-exposed groups (Valenca et al., 2006[<xref rid="R189" ref-type="bibr">189</xref>]).</p></sec><sec><title>Role of specific pollutants in NF-&#954;B activation</title><p>Sulfur-containing fossil fuels are the main source of sulphur dioxide (SO<sub>2</sub>), a colorless gas with a strong odor. It has a role in acid rain generation and air pollution (Blum et al., 2023[<xref rid="R26" ref-type="bibr">26</xref>]; Chen et al., 2022[<xref rid="R36" ref-type="bibr">36</xref>]). Inhaling SO<sub>2</sub> can cause respiratory problems, including difficulty breathing. It is a major air pollutant that is controlled to safeguard the public's health and the environment (Guo et al., 2021[<xref rid="R70" ref-type="bibr">70</xref>]). Yun et al. showed at low doses, their synergistic toxicity was shown, leading to considerable impairment in cell survival and apoptosis. Similar to how NF-&#954;B plays a role in smoking-induced lung cancer, the mechanism included the generation of ROS and the activation of NF-&#954;B, highlighting the need of taking into account interactions between pollutants (Yun et al., 2015[<xref rid="R204" ref-type="bibr">204</xref>]). </p></sec><sec><title>COX pathways and proinflammatory mediators</title><p>The enzyme cyclooxygenase-2 (COX-2) is in charge of producing prostaglandins, which are inflammatory mediators (Bernard et al., 2008[<xref rid="R16" ref-type="bibr">16</xref>]). In contrast to COX-1, COX-2 is induced and frequently increased in response to stimuli that cause inflammation (Dor&#233;, 2011[<xref rid="R53" ref-type="bibr">53</xref>]). Because COX-2 overexpression is linked to a number of illnesses, such as cancer and inflammatory ailments, it is a target for therapeutic therapies (Frejborg et al., 2020[<xref rid="R63" ref-type="bibr">63</xref>]). Ratovitski et al. examined the effect of cigarette smoke on the transcriptional control of inflammatory molecules, with NF-&#954;B being the main emphasis. When primary and secondary smoking were modeled using extracts from mainstream and sidestream smoke, it was shown that there was dose-dependent downregulation of LKB1 and overexpression of PEA3 and COX-2 proteins. Endogenous ChIP study demonstrated that NF-&#954;B binds to the COX-2 promoter and forms compounds in lung tumor cells exposed to cigarette extracts. These findings underscore the significance of inflammation in the carcinogenesis of epithelial cells by highlighting a unique relationship between transcription factors, most notably NF-&#954;B, and the cellular response to cigarette smoke (Ratovitski, 2010[<xref rid="R161" ref-type="bibr">161</xref>]). Further, Baglole et al. show that compared to wild-type (AhR(+/+)) fibroblasts, lung fibroblasts without the AhR gene (AhR(-/-)) show an increased inflammatory reaction to smoking from cigarettes, which is characterized by higher levels of prostaglandins (PGs) and COX-2. Transient transfection was used to validate AhR expression, and it showed a substantial reduction in smoke-induced COX-2 and PG production in AhR(-/-) fibroblasts, indicating the anti-inflammatory activity of AhR. Although AhR and NF-&#954;B interact, the increased inflammatory response in AhR(-/-) fibroblasts is linked to RelB loss rather than NF-&#954;B (p50/p65) activation. This emphasizes AhR and RelB's possible therapeutic target in treating disorders associated with inflammation (Baglole et al., 2008[<xref rid="R9" ref-type="bibr">9</xref>]). </p><p>Specialized immune cells called sentinel cells serve as the body's first line of defense against infections or other dangers (Daigneault et al., 2010[<xref rid="R42" ref-type="bibr">42</xref>]; Gupta et al., 2023[<xref rid="R72" ref-type="bibr">72</xref>]). Because these cells are always keeping an eye on their environment, they are essential to the immune system's surveillance (Hodge et al., 2022[<xref rid="R83" ref-type="bibr">83</xref>]). Sentinel cells sense foreign invaders or aberrant cells, and when they do, they trigger an immunological response that activates other immune system components to get rid of the threat and keep the body healthy overall (Marciscano and Anandasabapathy, 2021[<xref rid="R133" ref-type="bibr">133</xref>]; Pitt et al., 2016[<xref rid="R151" ref-type="bibr">151</xref>]). Martey et al. investigated the significance of fibroblasts, specifically their function as "sentinel" cells that initiate inflammation by releasing proinflammatory chemicals such as prostaglandins. Through the promotion of chronic inflammation, the overexpression of COX-2 and excessive eicosanoid synthesis, which are found in early carcinogenesis, may establish a susceptibility to cancer. When normal human lung fibroblasts are exposed to cigarette smoke, NF-&#954;B activation-mediated prostaglandin production and COX-2 expression are elevated. This may be the first stage of epithelial transition, this persistent inflammatory condition (Martey et al., 2004[<xref rid="R134" ref-type="bibr">134</xref>]).</p></sec><sec><title>Role of Rel subtypes and alternative NF-&#954;B pathways</title><p>RelB is a transcription factor that belongs to the NF-&#954;B family and is involved in immune and inflammatory responses (Kim et al., 2023[<xref rid="R103" ref-type="bibr">103</xref>]; Millet et al., 2013[<xref rid="R138" ref-type="bibr">138</xref>]). RelB is not like other NF-&#954;B proteins in that it frequently suppresses the immune system (Mockenhaupt et al., 2021[<xref rid="R140" ref-type="bibr">140</xref>]). It controls genes involved in immunological tolerance and the development of lymphoid organs and creates alternative NF-&#954;B dimers (Navarro et al., 2023[<xref rid="R144" ref-type="bibr">144</xref>]). RelB is a possible therapeutic target for regulating immune responses since it is linked to a number of illnesses (Seet et al., 2021[<xref rid="R169" ref-type="bibr">169</xref>]). The function of RelB in controlling smoke-induced COX-2 protein production in pulmonary fibroblasts is examined by Zago et al. RelB deficiency reduces the production of COX-2 protein even in the presence of Cox-2 mRNA increase and activation of the NF-&#954;B pathway. The results show that whereas RelB has no effect on mRNA stability, it does have an effect on miR-146a baseline levels. Smoking cigarettes raises miR-146a only in cells that express RelB. While inhibiting miR-146a greatly increases COX-2 protein levels, it has little effect on RelB or Cox-2 mRNA stimulation by smoke. Accordingly, it is possible that a novel pathway, the RelB-miR-146a axis, regulates inflammation in reaction to pulmonary toxicants, particularly those associated with NF-&#954;B and smoking (Zago et al., 2014[<xref rid="R205" ref-type="bibr">205</xref>]).</p><p>In lung tissues, the carcinogens in CS, such as nitrosamines and polycyclic aromatic hydrocarbons, cause inflammatory reactions and genetic alterations (Armstrong et al., 2004[<xref rid="R5" ref-type="bibr">5</xref>]; Holme et al., 2023[<xref rid="R85" ref-type="bibr">85</xref>]; Thapa et al., 2023[<xref rid="R186" ref-type="bibr">186</xref>]). Prolonged exposure triggers the activation of oncogenic pathways, such as NF-&#954;B, which facilitates angiogenesis, cell survival, and proliferation (Kordiak et al., 2022[<xref rid="R105" ref-type="bibr">105</xref>]). Furthermore, the inflammation brought on by CS fosters the growth of tumors (Moorthy et al., 2015[<xref rid="R141" ref-type="bibr">141</xref>]). These interrelated factors support the development and spread of lung cancer, highlighting the crucial part that cigarette smoke plays in the etiology of this fatal illness (Petit et al., 2019[<xref rid="R150" ref-type="bibr">150</xref>]; Singh et al., 2018[<xref rid="R172" ref-type="bibr">172</xref>]). Yao et al. investigate the mechanism by which lung cancer in mice is produced by CS. RelA/p65&#8315;/&#8315; mice and WT mice were split into two groups and given either air or CS. When compared to WT mice exposed to air, CS-treated animals displayed increased lung weight, tumor multiplicity, and maximal tumor size. WT mice's longevity was markedly shortened by CS exposure, but myeloid cells with RelA/p65 deleted had a higher survival rate. Increased macrophage infiltration and higher Ki-67-positive cells were linked to CS-induced lung cancer development. According to the study, TNF&#945; and the myeloid cell RelA/p65 are important factors in the development of lung cancer brought on by CS (Yao et al., 2014[<xref rid="R201" ref-type="bibr">201</xref>]) (Table 1<xref rid="T1" ref-type="fig">(Tab. 1)</xref>; References in Table 1: Baglole et al., 2008[<xref rid="R9" ref-type="bibr">9</xref>]; Jin et al., 2019[<xref rid="R95" ref-type="bibr">95</xref>]; Liu et al., 2021[<xref rid="R123" ref-type="bibr">123</xref>]; Lu et al., 2018[<xref rid="R126" ref-type="bibr">126</xref>]; Ma et al., 2015[<xref rid="R128" ref-type="bibr">128</xref>]; Majumder et al., 2021[<xref rid="R131" ref-type="bibr">131</xref>]; Min et al., 2016[<xref rid="R139" ref-type="bibr">139</xref>]; Ratovitski, 2010[<xref rid="R161" ref-type="bibr">161</xref>]; Rioux and Castonguay, 2000[<xref rid="R163" ref-type="bibr">163</xref>]; Rohrer et al., 2010[<xref rid="R165" ref-type="bibr">165</xref>]; Sugano et al., 1998[<xref rid="R176" ref-type="bibr">176</xref>]; Sun et al., 2016[<xref rid="R177" ref-type="bibr">177</xref>]; Valenca et al., 2006[<xref rid="R189" ref-type="bibr">189</xref>]; Wang et al., 2021[<xref rid="R192" ref-type="bibr">192</xref>]; Yin et al., 2016[<xref rid="R202" ref-type="bibr">202</xref>]; Yun et al., 2015[<xref rid="R204" ref-type="bibr">204</xref>]; Zago et al., 2014[<xref rid="R205" ref-type="bibr">205</xref>]; Zhang et al., 2018[<xref rid="R208" ref-type="bibr">208</xref>]).</p></sec></sec><sec><title>Epigenetic Mechanisms in Smoking-Induced NF-&#954;B Activation</title><sec><title>METTL3 and m6A modification</title><p>METTL3 functions as a methyltransferase in the critical RNA regulatory process of N6-methyladenosine (m6A) modification (Chen et al., 2022[<xref rid="R32" ref-type="bibr">32</xref>]). On mRNA, it adds m6A markers. The m6A reader protein YTHDF2 mediates the degradation of mRNA (Chen et al., 2022[<xref rid="R33" ref-type="bibr">33</xref>]; Li et al., 2022[<xref rid="R120" ref-type="bibr">120</xref>]). YTHDF2 controls the activity of METTL3, which has an impact on translation and mRNA stability (Sun et al., 2023[<xref rid="R179" ref-type="bibr">179</xref>]). The dynamic interaction between YTHDF2 and METTL3 plays a major role in controlling post-transcriptional gene expression in cells (Wang et al., 2022[<xref rid="R194" ref-type="bibr">194</xref>]). Jin et al. showed smoking cigarettes causes aberrant m6A alteration, which is connected to the development of NSCLC. The m6A METTL3 and the m6A YTHDF2 facilitate this change, which results in a reduction in the stability and expression of DAPK2 mRNA. The m6A METTL3 and m6A YTHDF2 mediate this change. Additionally, the study shows that DAPK2 suppresses tumors and that its downregulation increases the capacity for migration and proliferation by triggering the NF-&#954;B signaling pathway. The results show that smoking cigarettes alters DAPK2, which may be a therapeutic target for patients with NSCLC caused by smoking and provide new information on the mechanisms behind the development of NSCLC (Jin et al., 2021[<xref rid="R94" ref-type="bibr">94</xref>]). Similarly, According to Wang et al.'s analysis, cells exposed to lung cancer and cigarettes expressed less of the m6A reader protein YTHDC2. The relationship between lower YTHDC2, smoking history, and a bad prognosis is demonstrated via tissue analysis and bioinformatics. <italic toggle="yes">In vivo</italic>, confirmation of YTHDC2 overexpression inhibits lung cancer cell migration and proliferation. In lung cancer, YTHDC2 decrease is modulated by copy number deletion. Notably, m6A alteration mediates YTHDC2's action as a tumor suppressor via the CYLD/NF-&#954;B pathway, indicating a crucial connection between smoking-related YTHDC2 downregulation and accelerated lung cancer development (Wang et al., 2021[<xref rid="R192" ref-type="bibr">192</xref>]) (Figure 3<xref rid="F3" ref-type="fig">(Fig. 3)</xref>).</p></sec><sec><title>Histone modifications</title><p>Histone modifications, such as acetylation, methylation, and phosphorylation, play a crucial role in regulating chromatin structure and gene expression. NF-&#954;B activation in response to smoking can lead to changes in histone acetylation and methylation patterns, which affect the transcriptional activity of various genes involved in inflammation and tumorigenesis (Adcock et al., 2006[<xref rid="R2" ref-type="bibr">2</xref>]; Barnes, 2011[<xref rid="R14" ref-type="bibr">14</xref>]; Kaur et al., 2022[<xref rid="R100" ref-type="bibr">100</xref>]). Smoking-induced NF-&#954;B activation can increase histone acetylation at specific gene promoters, enhancing the expression of pro-inflammatory cytokines and other oncogenic factors (Kaur et al., 2018[<xref rid="R100" ref-type="bibr">100</xref>]). Histone acetyltransferases (HATs) like p300/CBP are recruited to the promoters of NF-&#954;B target genes, leading to increased acetylation of histones H3 and H4, which promotes gene transcription. Conversely, histone deacetylases (HDACs) can be involved in repressing the transcription of tumor suppressor genes. Smoking can disrupt the balance between HATs and HDACs, leading to aberrant gene expression patterns that favor cancer progression (Cui et al., 2013[<xref rid="R41" ref-type="bibr">41</xref>]).</p></sec><sec><title>DNA methylation</title><p>DNA methylation is another epigenetic mechanism influenced by NF-&#954;B activation in smoking-induced lung cancer. NF-&#954;B can interact with DNA methyltransferases (DNMTs) to modulate the methylation status of specific gene promoters (Asgarova et al., 2018[<xref rid="R7" ref-type="bibr">7</xref>]; Barnes, 2011[<xref rid="R14" ref-type="bibr">14</xref>]). Hypermethylation of tumor suppressor genes and hypomethylation of oncogenes are common features observed in smoking-related lung cancer (Kaur and Batra, 2020[<xref rid="R99" ref-type="bibr">99</xref>]). The promoter regions of tumor suppressor genes, such as p16 and RASSF1A, can become hypermethylated in response to chronic smoking, leading to their silencing and subsequent loss of tumor-suppressive functions (Liu et al., 2023[<xref rid="R124" ref-type="bibr">124</xref>]). NF-&#954;B-mediated recruitment of DNMTs to these promoters contributes to the epigenetic silencing of crucial regulatory genes, promoting cancer development (Xiong et al., 2019[<xref rid="R200" ref-type="bibr">200</xref>]).</p></sec><sec><title>Non-coding RNAs</title><p>Non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are also regulated by NF-&#954;B and play significant roles in smoking-induced lung carcinogenesis (Barangi et al., 2023[<xref rid="R13" ref-type="bibr">13</xref>]). NF-&#954;B can modulate the expression of various miRNAs that act as either oncogenes or tumor suppressors. miR-21, an oncogenic miRNA, is upregulated in response to smoking-induced NF-&#954;B activation (Chen et al., 2021[<xref rid="R35" ref-type="bibr">35</xref>]). MiR-21 targets and downregulates tumor suppressor genes such as PTEN, leading to enhanced cell survival and proliferation (Elton et al., 2013[<xref rid="R57" ref-type="bibr">57</xref>]). Conversely, tumor-suppressive miRNAs like miR-34a can be downregulated by smoking, further contributing to lung cancer progression (Kolenda et al., 2020[<xref rid="R104" ref-type="bibr">104</xref>]). LncRNAs, such as MALAT1, are also involved in NF-&#954;B-mediated epigenetic regulation. MALAT1 has been shown to interact with NF-&#954;B and other chromatin-modifying proteins to influence gene expression patterns associated with inflammation and cancer (Goodarzi et al., 2023[<xref rid="R69" ref-type="bibr">69</xref>]) (Figure 4<xref rid="F4" ref-type="fig">(Fig. 4)</xref>).</p></sec></sec><sec><title>Therapeutic Interventions</title><p>Extensive research has focused on elucidating NF-&#954;B's role in smoking-induced lung cancer. Activated by cigarette smoke, NF-&#954;B emerges as a pivotal molecular player, fostering tumorigenesis and progression (Hasnis et al., 2007[<xref rid="R75" ref-type="bibr">75</xref>]). Cigarette smoke triggers sustained NF-&#954;B nuclear translocation, prompting the release of inflammatory mediators and heightened mucus cell secretion (Huang et al., 2022[<xref rid="R89" ref-type="bibr">89</xref>]). This smoking-induced NF-&#954;B activation intricately regulates downstream pathways linked to lung cancer (Mei et al., 2022[<xref rid="R137" ref-type="bibr">137</xref>]; Thapa et al., 2024[<xref rid="R180" ref-type="bibr">180</xref>]). Additionally, ongoing investigations explore NF-&#954;B inhibition as a potential therapeutic avenue for smoking-associated lung cancer (Ou et al., 2022[<xref rid="R145" ref-type="bibr">145</xref>]). A comprehensive understanding of the NF-&#954;B pathway's involvement in tobacco smoke-induced lung cancer holds promise for informing the development of effective therapeutic interventions (Preciado et al., 2008[<xref rid="R152" ref-type="bibr">152</xref>]).</p><sec><title>Natural compounds</title><p>Linalool is a naturally occurring terpene alcohol found in many flowers and spice plants (An et al., 2021[<xref rid="R4" ref-type="bibr">4</xref>]). It is classified as an acyclic monoterpenoid and has multiple commercial applications, primarily based on its pleasant scent, which is described as floral with a touch of spiciness (de Groot, 2019[<xref rid="R44" ref-type="bibr">44</xref>]). Linalool is a colorless oil and is used in the manufacturing of soaps, fragrances, and other products (Dos Santos &#201; et al., 2022[<xref rid="R54" ref-type="bibr">54</xref>]). It is also hydrogenated to give dihydro- and tetrahydrolinalool, which are more resilient fragrances (Jiang et al., 2023[<xref rid="R93" ref-type="bibr">93</xref>]). Linalool has various biological properties, including antimicrobial activity (Koriem and El-Qady, 2023[<xref rid="R106" ref-type="bibr">106</xref>]). In recent years, there has been interest in using linalool as an active packaging, for example, by injecting it into the space above the contents of food packaging or applying it to food (Levenberg et al., 2020[<xref rid="R117" ref-type="bibr">117</xref>]). Linalool was found to significantly reduce lung inflammation caused by chronic sclerosis in mice by Ma et al. (2015[<xref rid="R128" ref-type="bibr">128</xref>]). It prevented inflammatory cell infiltration and the generation of inflammatory cytokines like IL-6, TNF-&#945;, IL-8, IL-1&#946;, and MCP-1. Linalool also prevented lung MPO activity and pathological alterations. Furthermore, it dose-dependently inhibited the activation of NF-&#954;B produced by chronic sclerosis, thereby reducing chronic sclerosis-induced lung inflammation (Ma et al., 2015[<xref rid="R128" ref-type="bibr">128</xref>]; Thapa et al., 2023[<xref rid="R182" ref-type="bibr">182</xref>]). </p><p>Bromelain is an enzyme extract derived from the stems of pineapples, although it exists in all parts of the fresh pineapple (Arshad et al., 2014[<xref rid="R6" ref-type="bibr">6</xref>]). It is a complex combination of multiple endopeptidases of thiol and other compounds (Chobotova et al., 2010[<xref rid="R38" ref-type="bibr">38</xref>]). Bromelain has a history of folk medicine use and is currently used in various industries, such as cosmetics, as a topical medication, and as a meat tenderizer (Hikisz and Bernasinska-Slomczewska, 2021[<xref rid="R79" ref-type="bibr">79</xref>]; Thapa et al., 2023[<xref rid="R183" ref-type="bibr">183</xref>]). It has been studied for its various therapeutic applications, including its role as an antiedematous, fibrinolytic, anticancer, anti-inflammatory, antibiotic, anticoagulant, and antithrombotic agent (Hirche et al., 2020[<xref rid="R81" ref-type="bibr">81</xref>]; Kumar et al., 2023[<xref rid="R109" ref-type="bibr">109</xref>]). Bromelain has been shown to have anticancer effects by preventing nuclear factor &#954;B (NF-&#954;B) translocation and inducing G2/M arrest, which can disrupt normal apoptotic functions and help cancer cell transformation (Maurer, 2001[<xref rid="R135" ref-type="bibr">135</xref>]; Owoyele et al., 2020[<xref rid="R146" ref-type="bibr">146</xref>]). The study of Majumder et al. explored the impact of bromelain and ethanolic olive leaf extract on lung carcinogenesis. They found that the combination increases Nrf2 activity, decreases NF-&#954;B translocation, and regulates inflammatory indicators, making it a potential method to reduce lung cancer caused by smoking (Majumder et al., 2021[<xref rid="R131" ref-type="bibr">131</xref>]). </p><p>Diallyl trisulfide (DATS) is an organosulfur compound found in garlic, known for its various biological activities, particularly in the context of cancer prevention and treatment (Han et al., 2017[<xref rid="R74" ref-type="bibr">74</xref>]). It has been reported to selectively kill cancerous cells in the prostate and breast while leaving healthy cells unharmed, attributed to increased reactive oxygen species (ROS) within cancer cells (Hsieh et al., 2020[<xref rid="R88" ref-type="bibr">88</xref>]; Kanga et al., 2023[<xref rid="R98" ref-type="bibr">98</xref>]). DATS has been investigated as an anticancer and chemopreventive agent, with <italic toggle="yes">in vitro</italic> studies showing its potency in reducing cell viability and its lower toxicity to non-transformed cells (Kim et al., 2023[<xref rid="R102" ref-type="bibr">102</xref>]; Leung et al., 2020[<xref rid="R116" ref-type="bibr">116</xref>]). Additionally, DATS exhibits a range of activities, including anticancer chemotherapeutic (Lin et al., 2024[<xref rid="R121" ref-type="bibr">121</xref>]), immunostimulatory (Puccinelli and Stan, 2017[<xref rid="R154" ref-type="bibr">154</xref>]), antioxidative (Rauf et al., 2022[<xref rid="R162" ref-type="bibr">162</xref>]), hepatoprotective, anti-fibrotic, anti-estrogenic (Wu et al., 2011[<xref rid="R199" ref-type="bibr">199</xref>]), anti-metastatic, anti-inflammatory, and anti-angiogenic properties (Thapa et al., 2023[<xref rid="R186" ref-type="bibr">186</xref>]; Zeng et al., 2008[<xref rid="R206" ref-type="bibr">206</xref>]). It has also been shown to modulate disease states such as cancer, infection, and metabolic syndrome. Qu et al. found that garlic oil's DATS can reduce lung carcinogenesis induced by tobacco-specific nitrosamine NNK. When injected into an A/J mouse model, DATS significantly reduced lung tumor incidence. DATS enhanced <italic toggle="yes">F. rodentium</italic> bacteria in the gut microbiome, inhibiting tumor growth. It also inhibited inflammatory factors and negatively regulated NF-&#954;B signaling through the PPAR&#947; pathway, suggesting DATS as a potential new chemopreventive treatment for lung cancer caused by tobacco use (Qu et al., 2024[<xref rid="R157" ref-type="bibr">157</xref>]).</p></sec><sec><title>Pharmaceutical drugs</title><p>Celecoxib has been evaluated as a potential cancer chemopreventive and therapeutic drug in clinical trials for various types of cancer (B&#261;k and Krupa, 2023[<xref rid="R10" ref-type="bibr">10</xref>]; Thapa et al., 2023[<xref rid="R184" ref-type="bibr">184</xref>]). It has been shown to have anticancer properties by preventing nuclear factor &#954;B (NF-&#954;B) translocation and inducing G2/M arrest, which can disrupt normal apoptotic functions and help cancer cell transformation (Fidahic et al., 2017[<xref rid="R62" ref-type="bibr">62</xref>]). Celecoxib is extensively metabolized through cytochrome P450 2C9 (CYP2C9) and may have interactions with other medications (Krasselt and Baerwald, 2019[<xref rid="R107" ref-type="bibr">107</xref>]; Papageorgiou et al., 2016[<xref rid="R149" ref-type="bibr">149</xref>]). Shishodia et al. studied NF-&#954;B activation in lung cancer cells exposed to CSC. They found that celecoxib reduced persistent NF-&#954;B activation for up to 24 hours, inhibiting the activation, phosphorylation, degradation, and nuclear translocation of I-&#954;B elicited by CSC. Additionally, it inhibited the expression of genes reliant on NF-&#954;B, reducing inflammation, proliferation, and angiogenesis (Shishodia and Aggarwal, 2004[<xref rid="R170" ref-type="bibr">170</xref>]).</p><p>Angiotensin-(1-7) (Ang-(1-7)) is a vasoactive peptide of the renin-angiotensin system (RAS), which is generated mainly by angiotensin-converting enzyme 2 (ACE2) and exerts its actions via the Ang-(1-7)/ACE2/Mas axis (de Paula Gonzaga et al., 2020[<xref rid="R45" ref-type="bibr">45</xref>]). It is considered to be a main mechanism that counterbalances the vasoconstrictive actions of the classical RAS. Ang-(1-7) has been reported to release nitric oxide, induce diuresis, and have a vasodilatory effect, favoring a lowering of blood pressure (de Souza-Neto et al., 2018[<xref rid="R47" ref-type="bibr">47</xref>]; Lelis et al., 2019[<xref rid="R114" ref-type="bibr">114</xref>]). It is a heptapeptide found in the heart and kidneys, with concentrations six times higher in the kidney than in plasma, highlighting its role in renal homeostasis (Luna et al., 2023[<xref rid="R127" ref-type="bibr">127</xref>]). Ang-(1-7) has broad effects in the cardiovascular system, including vasodilatation, myocardial protection, antiarrhythmic, antihypertensive, and positive inotropic effects, as well as inhibition of pathological cardiac remodelling (Medina and Arnold, 2019[<xref rid="R136" ref-type="bibr">136</xref>]; Pan et al., 2018[<xref rid="R147" ref-type="bibr">147</xref>]). It also has favourable effects on metabolism by lessening insulin resistance. Ang-(1-7) is considered to be an endogenous ligand for the G protein-coupled receptor Mas (Rahimi et al., 2022[<xref rid="R158" ref-type="bibr">158</xref>]). Zhang et al. studied Angiotensin-(1-7) in relation to cigarette smoke-induced COPD in C57BL/6J mice. Although Ang-(1-7) could not stop emphysema and lung function deterioration caused by cigarette smoke, it successfully reduced lung fibrosis and inflammation. The study suggests Ang-(1-7) has potential in treating emphysema and lung function impairment, possibly through the NF-&#954;B pathway (Zhang et al., 2018[<xref rid="R208" ref-type="bibr">208</xref>]). </p><p>NSAIDs lower fever, lessen inflammation, and relieve pain. They function by preventing prostaglandins, which are molecules involved in the inflammatory response, from being produced (Bindu et al., 2020[<xref rid="R24" ref-type="bibr">24</xref>]; Ding, 2022[<xref rid="R51" ref-type="bibr">51</xref>]). NSAIDs, which are often used to treat ailments including arthritis, include aspirin, ibuprofen, and naproxen (Garc&#237;a-Rayado et al., 2018[<xref rid="R65" ref-type="bibr">65</xref>]). NSAIDs are useful, but they should be used carefully since they can cause gastrointestinal discomfort and should be taken for extended periods or at high doses (Gurpinar et al., 2014[<xref rid="R73" ref-type="bibr">73</xref>]; Panchal and Prince Sabina, 2023[<xref rid="R148" ref-type="bibr">148</xref>]). Rioux et al. found that NSAIDs can prevent lung tumor growth when NNK, a smoking-related carcinogen, is present. They found that COX-1 and -enzymes mediate the conversion of NNK into carcinogenic substances in human macrophages. NSAIDs, like acetylsalicylic acid and NS-398, decreased COX-dependent NNK activation by 66 % and 37 %, respectively. This suggested that inhibiting NF-kappaB activation may be a unique way to prevent lung cancer (Rioux and Castonguay, 2000[<xref rid="R163" ref-type="bibr">163</xref>]; Thapa et al., 2023[<xref rid="R185" ref-type="bibr">185</xref>]). </p></sec></sec><sec><title>Challenges and Future Directions</title><p>Lung cancer growth is specifically impacted by the precise processes of NF-&#954;B activation in response to stress caused by smoking, which are yet not fully understood. While it is known that cigarette smoke can activate NF-&#954;B, the detailed interplay between NF-&#954;B and other signaling pathways implicated in lung cancer development remains a subject of ongoing research. Not all smokers develop lung cancer, and the disease can also arise in lifetime non-smokers, indicating a complex interplay of genetic and environmental factors. Understanding the variability in disease susceptibility and the specific role of NF-&#954;B in this context is a significant challenge. The variation in disease susceptibility has stimulated interest in molecular epidemiologic investigations to better understand the molecular mechanisms underlying the link between smoking, NF-&#954;B, and lung cancer development.</p><p>Further research must focus on elucidating the exact mechanisms by which NF-&#954;B is activated in response to smoking-related stress, as well as its distinct roles in the development and progression of smoking-related lung cancer. Personalized therapy solutions will require the completion of extensive molecular epidemiology research to determine genetic and environmental variables that modify NF-&#954;B activity and its connection with smoking-induced lung cancer. It has potential to develop tailored therapy techniques that modify NF-&#954;B activity in lung cancer caused by smoking. This involves investigating drugs that can precisely target the NF-&#954;B signaling system, such as NF-&#954;B inhibitors, for the treatment and prevention of lung cancer caused by smoking.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In overview, study of the function of NF-&#954;B in smoking-induced lung cancer has shown a complicated web of molecular processes that play a role in the onset and spread of this deadly illness. This review has compiled important data and insights from a thorough investigation of the literature, illuminating the complex relationship between NF-&#954;B and the toxic breath of smoking-induced lung cancer. NF-&#954;B, a transcription factor with diverse cellular functions, emerges as a central orchestrator in the response to cigarette smoke exposure. Its activation is intricately linked to chronic inflammation, immune modulation, and cell survival - all pivotal processes in the pathogenesis of lung cancer. A thorough examination of NF-&#954;B's unique contributions is crucial because of the milieu that is favorable to cancer created by the interaction between this protein and the several carcinogens found in cigarette smoke. The pro-inflammatory and pro-survival activities of NF-&#954;B in the context of smoking-induced lung cancer underline its potential as a therapeutic target. Via clarifying the molecular pathways via which NF-&#954;B affects the development of cancer, scientists are able to identify important targets for intervention and prevention.</p></sec><sec><title>Declaration</title><sec><title>Ethics approval and consent to participate</title><p>Not applicable to a review article. </p></sec><sec><title>Consent for publication </title><p>All authors gave their consent for publication. </p></sec><sec><title>Availability of data and materials </title><p>Not applicable as no novel data were generated for this review article. </p></sec><sec sec-type="COI-statement"><title>Competing interests </title><p>No authors have any conflict of interest or competing interests to declare. </p></sec><sec><title>Funding </title><p>No funding was received to perform this study. </p></sec><sec><title>Author contributions </title><p>RT, EM, and AG researched the data. AAB, WHA, IK, SIA, and HA wrote the first draft of the manuscript. BGO, RM, HD, SKS, and GG edited the manuscript. KD was responsible for conceptualization and supervision. All authors reviewed and approved the final version of the manuscript. Kamal Dua is the guarantor of this work.</p></sec><sec><title>Acknowledgments </title><p>None.</p></sec></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Abubakar</surname><given-names>M</given-names></name><name name-style="western"><surname>Puppala</surname><given-names>ER</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Maharana</surname><given-names>KC</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Roshan</surname><given-names>S</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>BG</given-names></name><name name-style="western"><surname>Dua</surname><given-names>K</given-names></name><name name-style="western"><surname>Ali</surname><given-names>MK</given-names></name><name name-style="western"><surname>Dave</surname><given-names>P</given-names></name></person-group><article-title>Epigenetics of rhinovirus</article-title><source>Targeting epigenetics in inflammatory lung diseases</source><year>2023</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer</publisher-name><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1007/978-981-99-4780-5_11</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/978-981-99-4780-5_11</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Adcock</surname><given-names>IM</given-names></name><name name-style="western"><surname>Ford</surname><given-names>P</given-names></name><name name-style="western"><surname>Ito</surname><given-names>K</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><article-title>Epigenetics and airways disease</article-title><source>Respir Res</source><year>2006</year><volume>7</volume><issue>1</issue><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-7-21</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/1465-9921-7-21</pub-id><pub-id pub-id-type="pmid">16460559</pub-id><pub-id pub-id-type="pmcid">PMC1382219</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Aidinidou</surname><given-names>L</given-names></name><name name-style="western"><surname>Chatzikyriakidou</surname><given-names>A</given-names></name><name name-style="western"><surname>Giannopoulos</surname><given-names>A</given-names></name><name name-style="western"><surname>Karpa</surname><given-names>V</given-names></name><name name-style="western"><surname>Tzimou</surname><given-names>I</given-names></name><name name-style="western"><surname>Aidinidou</surname><given-names>E</given-names></name><etal/></person-group><article-title>Association of NFKB1, NKX2-5, GATA4 and RANKL gene polymorphisms with sporadic congenital heart disease in Greek patients</article-title><source>Balkan J Med Genet</source><year>2021</year><volume>24</volume><issue>1</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.2478/bjmg-2021-0014</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2478/bjmg-2021-0014</pub-id><pub-id pub-id-type="pmcid">PMC8366470</pub-id><pub-id pub-id-type="pmid">34447654</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>An</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ren</surname><given-names>JN</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Fan</surname><given-names>G</given-names></name><name name-style="western"><surname>Qu</surname><given-names>SS</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Recent updates on bioactive properties of linalool</article-title><source>Food Funct</source><year>2021</year><volume>12</volume><fpage>10370</fpage><lpage>10389</lpage><pub-id pub-id-type="doi">10.1039/d1fo02120f</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1039/d1fo02120f</pub-id><pub-id pub-id-type="pmid">34611674</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Armstrong</surname><given-names>B</given-names></name><name name-style="western"><surname>Hutchinson</surname><given-names>E</given-names></name><name name-style="western"><surname>Unwin</surname><given-names>J</given-names></name><name name-style="western"><surname>Fletcher</surname><given-names>T</given-names></name></person-group><article-title>Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis</article-title><source>Environ Health Perspect</source><year>2004</year><volume>112</volume><fpage>970</fpage><lpage>978</lpage><pub-id pub-id-type="doi">10.1289/ehp.6895</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1289/ehp.6895</pub-id><pub-id pub-id-type="pmid">15198916</pub-id><pub-id pub-id-type="pmcid">PMC1247189</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Arshad</surname><given-names>ZI</given-names></name><name name-style="western"><surname>Amid</surname><given-names>A</given-names></name><name name-style="western"><surname>Yusof</surname><given-names>F</given-names></name><name name-style="western"><surname>Jaswir</surname><given-names>I</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>K</given-names></name><name name-style="western"><surname>Loke</surname><given-names>SP</given-names></name></person-group><article-title>Bromelain: an overview of industrial application and purification strategies</article-title><source>Appl Microbiol Biotechnol</source><year>2014</year><volume>98</volume><fpage>7283</fpage><lpage>7297</lpage><pub-id pub-id-type="doi">10.1007/s00253-014-5889-y</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s00253-014-5889-y</pub-id><pub-id pub-id-type="pmid">24965557</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Asgarova</surname><given-names>A</given-names></name><name name-style="western"><surname>Asgarov</surname><given-names>K</given-names></name><name name-style="western"><surname>Godet</surname><given-names>Y</given-names></name><name name-style="western"><surname>Peixoto</surname><given-names>P</given-names></name><name name-style="western"><surname>Nadaradjane</surname><given-names>A</given-names></name><name name-style="western"><surname>Boyer-Guittaut</surname><given-names>M</given-names></name><etal/></person-group><article-title>PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma</article-title><source>Oncoimmunology</source><year>2018</year><volume>7</volume><issue>5</issue><fpage>e1423170</fpage><pub-id pub-id-type="doi">10.1080/2162402x.2017.1423170</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/2162402x.2017.1423170</pub-id><pub-id pub-id-type="pmid">29721376</pub-id><pub-id pub-id-type="pmcid">PMC5927541</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Aswini</surname><given-names>YB</given-names></name></person-group><article-title>The genomics of oral cancer and wound healing</article-title><source>J Indian Soc Pedod Prev Dent</source><year>2009</year><volume>27</volume><issue>1</issue><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.4103/0970-4388.50808</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.4103/0970-4388.50808</pub-id><pub-id pub-id-type="pmid">19414966</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Baglole</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Maggirwar</surname><given-names>SB</given-names></name><name name-style="western"><surname>Gasiewicz</surname><given-names>TA</given-names></name><name name-style="western"><surname>Thatcher</surname><given-names>TH</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>RP</given-names></name><name name-style="western"><surname>Sime</surname><given-names>PJ</given-names></name></person-group><article-title>The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>28944</fpage><lpage>28957</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800685200</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1074/jbc.M800685200</pub-id><pub-id pub-id-type="pmid">18697742</pub-id><pub-id pub-id-type="pmcid">PMC2570856</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>B&#261;k</surname><given-names>U</given-names></name><name name-style="western"><surname>Krupa</surname><given-names>A</given-names></name></person-group><article-title>Challenges and opportunities for celecoxib repurposing</article-title><source>Pharm Res</source><year>2023</year><volume>40</volume><fpage>2329</fpage><lpage>2345</lpage><pub-id pub-id-type="doi">10.1007/s11095-023-03571-4</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s11095-023-03571-4</pub-id><pub-id pub-id-type="pmid">37552383</pub-id><pub-id pub-id-type="pmcid">PMC10661717</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Balaga</surname><given-names>VKR</given-names></name><name name-style="western"><surname>Pradhan</surname><given-names>A</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Patel</surname><given-names>N</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>R</given-names></name><name name-style="western"><surname>Singla</surname><given-names>N</given-names></name></person-group><article-title>Morin: A comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers</article-title><source>Pharmacol Res</source><year>2023</year><volume>7</volume><fpage>100264</fpage><pub-id pub-id-type="doi">10.1016/j.prmcm.2023.100264</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.prmcm.2023.100264</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bao</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weng</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin/FPN/SLC7A11 signaling pathway</article-title><source>Free Radic Biol Med</source><year>2023</year><volume>201</volume><fpage>76</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2023.03.006</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2023.03.006</pub-id><pub-id pub-id-type="pmid">36933812</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Barangi</surname><given-names>S</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>AW</given-names></name><name name-style="western"><surname>Karimi</surname><given-names>G</given-names></name></person-group><article-title>The role of lncRNAs/miRNAs/Sirt1 axis in myocardial and cerebral injury</article-title><source>Cell Cycle</source><year>2023</year><volume>22</volume><fpage>1062</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1080/15384101.2023.2172265</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/15384101.2023.2172265</pub-id><pub-id pub-id-type="pmid">36703306</pub-id><pub-id pub-id-type="pmcid">PMC10081082</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Barnes</surname><given-names>PJ</given-names></name></person-group><article-title>Pathophysiology of allergic inflammation</article-title><source>Immunol Rev</source><year>2011</year><volume>242</volume><issue>1</issue><fpage>31</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01020.x</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01020.x</pub-id><pub-id pub-id-type="pmid">21682737</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Benowitz</surname><given-names>NL</given-names></name><name name-style="western"><surname>Donny</surname><given-names>EC</given-names></name><name name-style="western"><surname>Hatsukami</surname><given-names>DK</given-names></name></person-group><article-title>Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game</article-title><source>Addiction</source><year>2017</year><volume>112</volume><issue>1</issue><fpage>6</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/add.13534</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/add.13534</pub-id><pub-id pub-id-type="pmid">27555354</pub-id><pub-id pub-id-type="pmcid">PMC5518737</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bernard</surname><given-names>MP</given-names></name><name name-style="western"><surname>Bancos</surname><given-names>S</given-names></name><name name-style="western"><surname>Sime</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>RP</given-names></name></person-group><article-title>Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise</article-title><source>Curr Pharm Des</source><year>2008</year><volume>14</volume><fpage>2051</fpage><lpage>2060</lpage><pub-id pub-id-type="doi">10.2174/138161208785294654</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/138161208785294654</pub-id><pub-id pub-id-type="pmid">18691115</pub-id><pub-id pub-id-type="pmcid">PMC2745246</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhalla</surname><given-names>S</given-names></name><name name-style="western"><surname>Mehan</surname><given-names>S</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A</given-names></name><name name-style="western"><surname>Rehman</surname><given-names>MU</given-names></name></person-group><article-title>Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions</article-title><source>Neurosci Biobehav Rev</source><year>2022</year><volume>142</volume><fpage>104896</fpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2022.104896</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.neubiorev.2022.104896</pub-id><pub-id pub-id-type="pmid">36191807</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>M</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H</given-names></name><etal/></person-group><article-title>MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting</article-title><source>Pathol Res Pract</source><year>2024</year><volume>253</volume><fpage>154991</fpage><pub-id pub-id-type="doi">10.1016/j.prp.2023.154991</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.prp.2023.154991</pub-id><pub-id pub-id-type="pmid">38070223</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>N</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><etal/></person-group><article-title>A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-&#954;B signaling in inflammatory lung diseases</article-title><source>Int J Biol Macromol</source><year>2023</year><volume>253</volume><issue>Pt 4</issue><fpage>126951</fpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.126951</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.126951</pub-id><pub-id pub-id-type="pmid">37734525</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer</article-title><source>Cytokine</source><year>2023</year><volume>171</volume><fpage>156376</fpage><pub-id pub-id-type="doi">10.1016/j.cyto.2023.156376</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cyto.2023.156376</pub-id><pub-id pub-id-type="pmid">37748333</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>M</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Polyphenol-loaded nano-carriers for breast cancer therapy: a comprehensive review</article-title><source>BioNanoScience</source><year>2024</year><fpage>epub ahead of print</fpage><pub-id pub-id-type="doi">10.1007/s12668-023-01288-7</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s12668-023-01288-7</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><etal/></person-group><article-title>Unwinding circular RNA&#8217;s role in inflammatory pulmonary diseases</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2024</year><volume>397</volume><fpage>2567</fpage><lpage>2588</lpage><pub-id pub-id-type="doi">10.1007/s00210-023-02809-7</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s00210-023-02809-7</pub-id><pub-id pub-id-type="pmid">37917370</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Subramaniyan</surname><given-names>V</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Curcumin-based nanoformulations as an emerging therapeutic strategy for inflammatory lung diseases</article-title><source>Future Med Chem</source><year>2023</year><volume>15</volume><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.4155/fmc-2023-0048</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.4155/fmc-2023-0048</pub-id><pub-id pub-id-type="pmid">37140132</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bindu</surname><given-names>S</given-names></name><name name-style="western"><surname>Mazumder</surname><given-names>S</given-names></name><name name-style="western"><surname>Bandyopadhyay</surname><given-names>U</given-names></name></person-group><article-title>Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective</article-title><source>Biochem Pharmacol</source><year>2020</year><volume>180</volume><fpage>114147</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2020.114147</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.bcp.2020.114147</pub-id><pub-id pub-id-type="pmid">32653589</pub-id><pub-id pub-id-type="pmcid">PMC7347500</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Bitzer</surname><given-names>ZT</given-names></name><name name-style="western"><surname>Mocniak</surname><given-names>LE</given-names></name><name name-style="western"><surname>Trushin</surname><given-names>N</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M</given-names></name><name name-style="western"><surname>Richie</surname><given-names>JP</given-names></name></person-group><article-title>Influence of tobacco variety and curing on free radical production in cigarette smoke</article-title><source>Nicotine Tob Res</source><year>2023</year><volume>25</volume><fpage>1400</fpage><lpage>1405</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntad049</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/ntr/ntad049</pub-id><pub-id pub-id-type="pmid">36967618</pub-id><pub-id pub-id-type="pmcid">PMC10256888</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Blum</surname><given-names>TG</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>RL</given-names></name><name name-style="western"><surname>Durieux</surname><given-names>V</given-names></name><name name-style="western"><surname>Chorostowska-Wynimko</surname><given-names>J</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>DR</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>J</given-names></name><etal/></person-group><article-title>European Respiratory Society guideline on various aspects of quality in lung cancer care</article-title><source>Eur Respir J</source><year>2023</year><volume>61</volume><issue>2</issue><fpage>2103201</fpage><pub-id pub-id-type="doi">10.1183/13993003.03201-2021</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1183/13993003.03201-2021</pub-id><pub-id pub-id-type="pmid">36396145</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Breitbarth</surname><given-names>AK</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>J</given-names></name><name name-style="western"><surname>Jones</surname><given-names>AL</given-names></name></person-group><article-title>E-cigarettes - An unintended illicit drug delivery system</article-title><source>Drug Alcohol Depend</source><year>2018</year><volume>192</volume><fpage>98</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.07.031</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.07.031</pub-id><pub-id pub-id-type="pmid">30245461</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Brown</surname><given-names>BG</given-names></name><name name-style="western"><surname>Borschke</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Doolittle</surname><given-names>DJ</given-names></name></person-group><article-title>An analysis of the role of tobacco-specific nitrosamines in the carcinogenicity of tobacco smoke</article-title><source>Nonlinearity Biol Toxicol Med</source><year>2003</year><volume>1</volume><fpage>179</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1080/15401420391434324</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/15401420391434324</pub-id><pub-id pub-id-type="pmid">19330121</pub-id><pub-id pub-id-type="pmcid">PMC2651603</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Cai</surname><given-names>B</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Cigarette smoke extract amplifies NADPH oxidase-dependent ROS production to inactivate PTEN by oxidation in BEAS-2B cells</article-title><source>Food Chem Toxicol</source><year>2021</year><volume>150</volume><fpage>112050</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2021.112050</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.fct.2021.112050</pub-id><pub-id pub-id-type="pmid">33577944</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Cartwright</surname><given-names>T</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>ND</given-names></name><name name-style="western"><surname>C</surname><given-names>LW</given-names></name></person-group><article-title>NFKB1: a suppressor of inflammation, ageing and cancer</article-title><source>Febs J</source><year>2016</year><volume>283</volume><fpage>1812</fpage><lpage>1822</lpage><pub-id pub-id-type="doi">10.1111/febs.13627</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/febs.13627</pub-id><pub-id pub-id-type="pmid">26663363</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chang</surname><given-names>JT</given-names></name><name name-style="western"><surname>Anic</surname><given-names>GM</given-names></name><name name-style="western"><surname>Rostron</surname><given-names>BL</given-names></name><name name-style="western"><surname>Tanwar</surname><given-names>M</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CM</given-names></name></person-group><article-title>Cigarette smoking reduction and health risks: a systematic review and meta-analysis</article-title><source>Nicotine Tob Res</source><year>2021</year><volume>23</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntaa156</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/ntr/ntaa156</pub-id><pub-id pub-id-type="pmid">32803250</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wong</surname><given-names>CC</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1/CXCR2 axis to promote colorectal cancer</article-title><source>Gastroenterology</source><year>2022</year><volume>163</volume><fpage>891</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2022.06.024</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1053/j.gastro.2022.06.024</pub-id><pub-id pub-id-type="pmid">35700773</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>50</volume><fpage>11619</fpage><lpage>11634</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1027</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/nar/gkac1027</pub-id><pub-id pub-id-type="pmid">36399511</pub-id><pub-id pub-id-type="pmcid">PMC9723618</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chen</surname><given-names>QJ</given-names></name><name name-style="western"><surname>Lai</surname><given-names>HM</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YT</given-names></name><name name-style="western"><surname>Li</surname><given-names>XM</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association between the NFKB1-94ins/del ATTG polymorphism (rs28362491) and coronary artery disease: a systematic review and meta-analysis</article-title><source>Genet Test Mol Biomarkers</source><year>2016</year><volume>20</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1089/gtmb.2015.0242</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1089/gtmb.2015.0242</pub-id><pub-id pub-id-type="pmid">26799199</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name></person-group><article-title>Long non-coding RNAs: From disease code to drug role</article-title><source>Acta Pharm Sin B</source><year>2021</year><volume>11</volume><fpage>340</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.apsb.2020.10.001</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.apsb.2020.10.001</pub-id><pub-id pub-id-type="pmid">33643816</pub-id><pub-id pub-id-type="pmcid">PMC7893121</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Health effects of exposure to sulfur dioxide, nitrogen dioxide, ozone, and carbon monoxide between 1980 and 2019: A systematic review and meta-analysis</article-title><source>Indoor Air</source><year>2022</year><volume>32</volume><issue>11</issue><fpage>e13170</fpage><pub-id pub-id-type="doi">10.1111/ina.13170</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/ina.13170</pub-id><pub-id pub-id-type="pmid">36437665</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chiang</surname><given-names>HC</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>M</given-names></name><name name-style="western"><surname>Chang</surname><given-names>WL</given-names></name></person-group><article-title>The role of microbiota in esophageal squamous cell carcinoma: A review of the literature</article-title><source>Thorac Cancer</source><year>2023</year><volume>14</volume><fpage>2821</fpage><lpage>2829</lpage><pub-id pub-id-type="doi">10.1111/1759-7714.15096</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/1759-7714.15096</pub-id><pub-id pub-id-type="pmid">37675608</pub-id><pub-id pub-id-type="pmcid">PMC10542467</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Chobotova</surname><given-names>K</given-names></name><name name-style="western"><surname>Vernallis</surname><given-names>AB</given-names></name><name name-style="western"><surname>Majid</surname><given-names>FA</given-names></name></person-group><article-title>Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives</article-title><source>Cancer Lett</source><year>2010</year><volume>290</volume><fpage>148</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2009.08.001</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.canlet.2009.08.001</pub-id><pub-id pub-id-type="pmid">19700238</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Conlon</surname><given-names>TM</given-names></name><name name-style="western"><surname>John-Schuster</surname><given-names>G</given-names></name><name name-style="western"><surname>Heide</surname><given-names>D</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>D</given-names></name><name name-style="western"><surname>Lehmann</surname><given-names>M</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhibition of LT&#946;R signalling activates WNT-induced regeneration in lung</article-title><source>Nature</source><year>2020</year><volume>588</volume><issue>7836</issue><fpage>151</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2882-8</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1038/s41586-020-2882-8</pub-id><pub-id pub-id-type="pmid">33149305</pub-id><pub-id pub-id-type="pmcid">PMC7718297</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Crosbie</surname><given-names>E</given-names></name><name name-style="western"><surname>Hartman</surname><given-names>J</given-names></name><name name-style="western"><surname>Tran</surname><given-names>B</given-names></name><name name-style="western"><surname>Bialous</surname><given-names>S</given-names></name></person-group><article-title>Promoting healthier options? Inside the branding of light cigarettes and targeting youth in Brazil</article-title><source>Glob Public Health</source><year>2022</year><volume>17</volume><fpage>1913</fpage><lpage>1923</lpage><pub-id pub-id-type="doi">10.1080/17441692.2021.2003840</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/17441692.2021.2003840</pub-id><pub-id pub-id-type="pmid">34852728</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Cui</surname><given-names>ZL</given-names></name><name name-style="western"><surname>Gu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ding</surname><given-names>T</given-names></name><name name-style="western"><surname>Peng</surname><given-names>XH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Luan</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Histone modifications of Notch1 promoter affect lung CD4+ T cell differentiation in asthmatic rats</article-title><source>Int J Immunopathol Pharmacol</source><year>2013</year><volume>26</volume><fpage>371</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1177/039463201302600210</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1177/039463201302600210</pub-id><pub-id pub-id-type="pmid">23755752</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Daigneault</surname><given-names>M</given-names></name><name name-style="western"><surname>Preston</surname><given-names>JA</given-names></name><name name-style="western"><surname>Marriott</surname><given-names>HM</given-names></name><name name-style="western"><surname>Whyte</surname><given-names>MK</given-names></name><name name-style="western"><surname>Dockrell</surname><given-names>DH</given-names></name></person-group><article-title>The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>1</issue><fpage>e8668</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0008668</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0008668</pub-id><pub-id pub-id-type="pmid">20084270</pub-id><pub-id pub-id-type="pmcid">PMC2800192</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dang</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Ning</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>J</given-names></name><name name-style="western"><surname>Niu</surname><given-names>G</given-names></name><etal/></person-group><article-title>Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-&#954;B pathways</article-title><source>Respir Res</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>95</fpage><pub-id pub-id-type="doi">10.1186/s12931-020-01358-4</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/s12931-020-01358-4</pub-id><pub-id pub-id-type="pmid">32321531</pub-id><pub-id pub-id-type="pmcid">PMC7178609</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>de Groot</surname><given-names>A</given-names></name></person-group><article-title>Linalool hydroperoxides</article-title><source>Dermatitis</source><year>2019</year><volume>30</volume><fpage>243</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1097/der.0000000000000471</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1097/der.0000000000000471</pub-id><pub-id pub-id-type="pmid">31313746</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>de Paula Gonzaga</surname><given-names>A</given-names></name><name name-style="western"><surname>Palmeira</surname><given-names>VA</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>TFS</given-names></name><name name-style="western"><surname>Costa</surname><given-names>LB</given-names></name><name name-style="western"><surname>de S&#225; Rodrigues</surname><given-names>KE</given-names></name><name name-style="western"><surname>Sim&#245;es</surname><given-names>ESAC</given-names></name></person-group><article-title>ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: potential role for pediatric tumors</article-title><source>Curr Drug Targets</source><year>2020</year><volume>21</volume><fpage>892</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.2174/1389450121666200210124217</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1389450121666200210124217</pub-id><pub-id pub-id-type="pmid">32039680</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>de Sousa</surname><given-names>VML</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>L</given-names></name></person-group><article-title>Heterogeneity in lung cancer</article-title><source>Pathobiology</source><year>2018</year><volume>85</volume><issue>1-2</issue><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1159/000487440</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1159/000487440</pub-id><pub-id pub-id-type="pmid">29635240</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>de Souza-Neto</surname><given-names>FP</given-names></name><name name-style="western"><surname>Carvalho Santuchi</surname><given-names>M</given-names></name><name name-style="western"><surname>de Morais</surname><given-names>ESM</given-names></name><name name-style="western"><surname>Campagnole-Santos</surname><given-names>MJ</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>RF</given-names></name></person-group><article-title>Angiotensin-(1-7) and alamandine on experimental models of hypertension and atherosclerosis</article-title><source>Curr Hypertens Rep</source><year>2018</year><volume>20</volume><issue>2</issue><fpage>17</fpage><pub-id pub-id-type="doi">10.1007/s11906-018-0798-6</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s11906-018-0798-6</pub-id><pub-id pub-id-type="pmid">29541937</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dela Cruz</surname><given-names>CS</given-names></name><name name-style="western"><surname>Tanoue</surname><given-names>LT</given-names></name><name name-style="western"><surname>Matthay</surname><given-names>RA</given-names></name></person-group><article-title>Lung cancer: epidemiology, etiology, and prevention</article-title><source>Clin Chest Med</source><year>2011</year><volume>32</volume><fpage>605</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.ccm.2011.09.001</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.ccm.2011.09.001</pub-id><pub-id pub-id-type="pmid">22054876</pub-id><pub-id pub-id-type="pmcid">PMC3864624</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Deng</surname><given-names>M</given-names></name><name name-style="western"><surname>Tong</surname><given-names>R</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hou</surname><given-names>G</given-names></name></person-group><article-title>Astaxanthin attenuates cigarette smoking-induced oxidative stress and inflammation in a sirtuin 1-dependent manner</article-title><source>Biomed Pharmacother</source><year>2023</year><volume>159</volume><fpage>114230</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114230</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114230</pub-id><pub-id pub-id-type="pmid">36696799</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>DiDonato</surname><given-names>JA</given-names></name><name name-style="western"><surname>Mercurio</surname><given-names>F</given-names></name><name name-style="western"><surname>Karin</surname><given-names>M</given-names></name></person-group><article-title>NF-&#954;B and the link between inflammation and cancer</article-title><source>Immunol Rev</source><year>2012</year><volume>246</volume><issue>1</issue><fpage>379</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2012.01099.x</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/j.1600-065X.2012.01099.x</pub-id><pub-id pub-id-type="pmid">22435567</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ding</surname><given-names>C</given-names></name></person-group><article-title>Do NSAIDs affect the progression of osteoarthritis?</article-title><source>Inflammation</source><year>2002</year><volume>26</volume><fpage>139</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1023/a:1015504632021</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1023/a:1015504632021</pub-id><pub-id pub-id-type="pmid">12083420</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ding</surname><given-names>YS</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Jain</surname><given-names>RB</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N</given-names></name><name name-style="western"><surname>Wang</surname><given-names>RY</given-names></name><name name-style="western"><surname>Ashley</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Levels of tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons in mainstream smoke from different tobacco varieties</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2008</year><volume>17</volume><fpage>3366</fpage><lpage>3371</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.Epi-08-0320</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1158/1055-9965.Epi-08-0320</pub-id><pub-id pub-id-type="pmid">19064552</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dor&#233;</surname><given-names>M</given-names></name></person-group><article-title>Cyclooxygenase-2 expression in animal cancers</article-title><source>Vet Pathol</source><year>2011</year><volume>48</volume><issue>1</issue><fpage>254</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1177/0300985810379434</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1177/0300985810379434</pub-id><pub-id pub-id-type="pmid">20876365</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dos Santos &#201;</surname><given-names>RQ</given-names></name><name name-style="western"><surname>Maia</surname><given-names>JGS</given-names></name><name name-style="western"><surname>Fontes-J&#250;nior</surname><given-names>EA</given-names></name><name name-style="western"><surname>do Socorro Ferraz Maia</surname><given-names>C</given-names></name></person-group><article-title>Linalool as a therapeutic and medicinal tool in depression treatment: a review</article-title><source>Curr Neuropharmacol</source><year>2022</year><volume>20</volume><fpage>1073</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.2174/1570159x19666210920094504</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1570159x19666210920094504</pub-id><pub-id pub-id-type="pmid">34544345</pub-id><pub-id pub-id-type="pmcid">PMC9886818</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Dubin</surname><given-names>S</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>D</given-names></name></person-group><article-title>Lung cancer in non-smokers</article-title><source>Mo Med</source><year>2020</year><volume>117</volume><issue>4</issue><fpage>375</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">32848276</pub-id><pub-id pub-id-type="pmcid">PMC7431055</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Edwards</surname><given-names>SH</given-names></name><name name-style="western"><surname>Hassink</surname><given-names>MD</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>KM</given-names></name><name name-style="western"><surname>Watson</surname><given-names>CH</given-names></name><name name-style="western"><surname>Kuklenyik</surname><given-names>P</given-names></name><name name-style="western"><surname>Kimbrell</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tobacco-specific nitrosamines in the tobacco and mainstream smoke of commercial little cigars</article-title><source>Chem Res Toxicol</source><year>2021</year><volume>34</volume><fpage>1034</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrestox.0c00367</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1021/acs.chemrestox.0c00367</pub-id><pub-id pub-id-type="pmid">33667338</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Elton</surname><given-names>TS</given-names></name><name name-style="western"><surname>Selemon</surname><given-names>H</given-names></name><name name-style="western"><surname>Elton</surname><given-names>SM</given-names></name><name name-style="western"><surname>Parinandi</surname><given-names>NL</given-names></name></person-group><article-title>Regulation of the MIR155 host gene in physiological and pathological processes</article-title><source>Gene</source><year>2013</year><volume>532</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2012.12.009</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.gene.2012.12.009</pub-id><pub-id pub-id-type="pmid">23246696</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Eluard</surname><given-names>B</given-names></name><name name-style="western"><surname>Thieblemont</surname><given-names>C</given-names></name><name name-style="western"><surname>Baud</surname><given-names>V</given-names></name></person-group><article-title>NF-&#954;B in the new era of cancer therapy</article-title><source>Trends Cancer</source><year>2020</year><volume>6</volume><fpage>677</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/j.trecan.2020.04.003</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.trecan.2020.04.003</pub-id><pub-id pub-id-type="pmid">32409139</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Esc&#243;s</surname><given-names>A</given-names></name><name name-style="western"><surname>Mart&#237;n-G&#243;mez</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Romero</surname><given-names>D</given-names></name><name name-style="western"><surname>D&#237;az-Mora</surname><given-names>E</given-names></name><name name-style="western"><surname>Francisco-Velilla</surname><given-names>R</given-names></name><name name-style="western"><surname>Santiago</surname><given-names>C</given-names></name><etal/></person-group><article-title>TPL2 kinase expression is regulated by the p38&#947;/p38&#948;-dependent association of aconitase-1 with TPL2 mRNA</article-title><source>Proc Natl Acad Sci U S A</source><year>2022</year><volume>119</volume><issue>35</issue><fpage>e2204752119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2204752119</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1073/pnas.2204752119</pub-id><pub-id pub-id-type="pmid">35994673</pub-id><pub-id pub-id-type="pmcid">PMC9436348</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mao</surname><given-names>R</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>NF-&#954;B and STAT3 signaling pathways collaboratively link inflammation to cancer</article-title><source>Protein Cell</source><year>2013</year><volume>4</volume><fpage>176</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1007/s13238-013-2084-3</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s13238-013-2084-3</pub-id><pub-id pub-id-type="pmid">23483479</pub-id><pub-id pub-id-type="pmcid">PMC4875500</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Fang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Qi</surname><given-names>C</given-names></name><name name-style="western"><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Cigarette smoke extract combined with LPS down-regulates the expression of MRP2 in chronic pulmonary inflammation may be related to FXR</article-title><source>Mol Immunol</source><year>2021</year><volume>137</volume><fpage>174</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2021.06.019</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.molimm.2021.06.019</pub-id><pub-id pub-id-type="pmid">34273652</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Fidahic</surname><given-names>M</given-names></name><name name-style="western"><surname>Jelicic Kadic</surname><given-names>A</given-names></name><name name-style="western"><surname>Radic</surname><given-names>M</given-names></name><name name-style="western"><surname>Puljak</surname><given-names>L</given-names></name></person-group><article-title>Celecoxib for rheumatoid arthritis</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><volume>6</volume><issue>6</issue><fpage>Cd012095</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD012095.pub2</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/14651858.CD012095.pub2</pub-id><pub-id pub-id-type="pmid">28597983</pub-id><pub-id pub-id-type="pmcid">PMC6481589</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Frejborg</surname><given-names>E</given-names></name><name name-style="western"><surname>Salo</surname><given-names>T</given-names></name><name name-style="western"><surname>Salem</surname><given-names>A</given-names></name></person-group><article-title>Role of cyclooxygenase-2 in head and neck tumorigenesis</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>23</issue><fpage>9246</fpage><pub-id pub-id-type="doi">10.3390/ijms21239246</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/ijms21239246</pub-id><pub-id pub-id-type="pmid">33287464</pub-id><pub-id pub-id-type="pmcid">PMC7731111</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Gankhuyag</surname><given-names>N</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KH</given-names></name><name name-style="western"><surname>Cho</surname><given-names>JY</given-names></name></person-group><article-title>The role of nitrosamine (NNK) in breast cancer carcinogenesis</article-title><source>J Mammary Gland Biol Neoplasia</source><year>2017</year><volume>22</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1007/s10911-017-9381-z</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s10911-017-9381-z</pub-id><pub-id pub-id-type="pmid">28664511</pub-id><pub-id pub-id-type="pmcid">PMC5579148</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Garc&#237;a-Rayado</surname><given-names>G</given-names></name><name name-style="western"><surname>Navarro</surname><given-names>M</given-names></name><name name-style="western"><surname>Lanas</surname><given-names>A</given-names></name></person-group><article-title>NSAID induced gastrointestinal damage and designing GI-sparing NSAIDs</article-title><source>Expert Rev Clin Pharmacol</source><year>2018</year><volume>11</volume><fpage>1031</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1080/17512433.2018.1516143</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/17512433.2018.1516143</pub-id><pub-id pub-id-type="pmid">30139288</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Geffken</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Moon</surname><given-names>S</given-names></name><name name-style="western"><surname>Smith</surname><given-names>CO</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HH</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>K</given-names></name><etal/></person-group><article-title>Insulin and IGF-1 elicit robust transcriptional regulation to modulate autophagy in astrocytes</article-title><source>Mol Metab</source><year>2022</year><volume>66</volume><fpage>101647</fpage><pub-id pub-id-type="doi">10.1016/j.molmet.2022.101647</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.molmet.2022.101647</pub-id><pub-id pub-id-type="pmid">36503893</pub-id><pub-id pub-id-type="pmcid">PMC9731889</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Gellner</surname><given-names>CA</given-names></name><name name-style="western"><surname>Reynaga</surname><given-names>DD</given-names></name><name name-style="western"><surname>Leslie</surname><given-names>FM</given-names></name></person-group><article-title>Cigarette smoke extract: a preclinical model of tobacco dependence</article-title><source>Curr Protoc Neurosci</source><year>2016</year><volume>77</volume><fpage>9.54</fpage><pub-id pub-id-type="doi">10.1002/cpns.14</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/cpns.14</pub-id><pub-id pub-id-type="pmcid">PMC5113292</pub-id><pub-id pub-id-type="pmid">27696362</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Gon&#231;alves</surname><given-names>RB</given-names></name><name name-style="western"><surname>Coletta</surname><given-names>RD</given-names></name><name name-style="western"><surname>Silv&#233;rio</surname><given-names>KG</given-names></name><name name-style="western"><surname>Benevides</surname><given-names>L</given-names></name><name name-style="western"><surname>Casati</surname><given-names>MZ</given-names></name><name name-style="western"><surname>da Silva</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Impact of smoking on inflammation: overview of molecular mechanisms</article-title><source>Inflamm Res</source><year>2011</year><volume>60</volume><fpage>409</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1007/s00011-011-0308-7</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s00011-011-0308-7</pub-id><pub-id pub-id-type="pmid">21298317</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Goodarzi</surname><given-names>V</given-names></name><name name-style="western"><surname>Nouri</surname><given-names>S</given-names></name><name name-style="western"><surname>Nassaj</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Bighash</surname><given-names>M</given-names></name><name name-style="western"><surname>Abbasian</surname><given-names>S</given-names></name><name name-style="western"><surname>Hagh</surname><given-names>RA</given-names></name></person-group><article-title>Long non coding RNAs reveal important pathways in childhood asthma: a future perspective</article-title><source>J Mol Histol</source><year>2023</year><volume>54</volume><fpage>257</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1007/s10735-023-10131-y</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s10735-023-10131-y</pub-id><pub-id pub-id-type="pmid">37537509</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Guo</surname><given-names>H</given-names></name><name name-style="western"><surname>Wei</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Ho</surname><given-names>HC</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Do socioeconomic factors modify the effects of PM1 and SO2 on lung cancer incidence in China?</article-title><source>Sci Total Environ</source><year>2021</year><volume>756</volume><fpage>143998</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.143998</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.143998</pub-id><pub-id pub-id-type="pmid">33310217</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name></person-group><article-title>NFKB1-mediated downregulation of microRNA-106a promotes oxidative stress injury and insulin resistance in mice with gestational hypertension</article-title><source>Cytotechnology</source><year>2021</year><volume>73</volume><issue>1</issue><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1007/s10616-020-00448-x</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s10616-020-00448-x</pub-id><pub-id pub-id-type="pmid">33505119</pub-id><pub-id pub-id-type="pmcid">PMC7817744</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>MS</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Dahiya</surname><given-names>R</given-names></name><name name-style="western"><surname>Mahapatra</surname><given-names>DK</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19</article-title><source>Regen Med</source><year>2023</year><volume>18</volume><fpage>675</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.2217/rme-2023-0077</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2217/rme-2023-0077</pub-id><pub-id pub-id-type="pmid">37554111</pub-id><pub-id pub-id-type="pmcid">PMC10411327</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Gurpinar</surname><given-names>E</given-names></name><name name-style="western"><surname>Grizzle</surname><given-names>WE</given-names></name><name name-style="western"><surname>Piazza</surname><given-names>GA</given-names></name></person-group><article-title>NSAIDs inhibit tumorigenesis, but how?</article-title><source>Clin Cancer Res</source><year>2014</year><volume>20</volume><fpage>1104</fpage><lpage>1113</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.Ccr-13-1573</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1158/1078-0432.Ccr-13-1573</pub-id><pub-id pub-id-type="pmid">24311630</pub-id><pub-id pub-id-type="pmcid">PMC3947450</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Diallyl trisulfide (DATS) suppresses benzene-induced cytopenia by modulating haematopoietic cell apoptosis</article-title><source>Environ Pollut</source><year>2017</year><volume>231</volume><issue>Pt 1</issue><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.envpol.2017.07.069</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.envpol.2017.07.069</pub-id><pub-id pub-id-type="pmid">28810199</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hasnis</surname><given-names>E</given-names></name><name name-style="western"><surname>Bar-Shai</surname><given-names>M</given-names></name><name name-style="western"><surname>Burbea</surname><given-names>Z</given-names></name><name name-style="western"><surname>Reznick</surname><given-names>AZ</given-names></name></person-group><article-title>Mechanisms underlying cigarette smoke-induced NF-kappaB activation in human lymphocytes: the role of reactive nitrogen species</article-title><source>J Physiol Pharmacol</source><year>2007</year><volume>58</volume><issue>Suppl 5</issue><fpage>275</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">18204137</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Luo</surname><given-names>L</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>S</given-names></name></person-group><article-title>PRMT6 mediates inflammation via activation of the NF-&#954;B/p65 pathway on a cigarette smoke extract-induced murine emphysema model</article-title><source>Tob Induc Dis</source><year>2020</year><volume>18</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.18332/tid/116413</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.18332/tid/116413</pub-id><pub-id pub-id-type="pmid">32047419</pub-id><pub-id pub-id-type="pmcid">PMC7008391</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hellstrom</surname><given-names>A</given-names></name><name name-style="western"><surname>Ley</surname><given-names>D</given-names></name><name name-style="western"><surname>Hallberg</surname><given-names>B</given-names></name><name name-style="western"><surname>Lofqvist</surname><given-names>C</given-names></name><name name-style="western"><surname>Hansen-Pupp</surname><given-names>I</given-names></name><name name-style="western"><surname>Ramenghi</surname><given-names>LA</given-names></name><etal/></person-group><article-title>IGF-1 as a drug for preterm infants: a step-wise clinical development</article-title><source>Curr Pharm Des</source><year>2017</year><volume>23</volume><fpage>5964</fpage><lpage>5970</lpage><pub-id pub-id-type="doi">10.2174/1381612823666171002114545</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1381612823666171002114545</pub-id><pub-id pub-id-type="pmid">28969546</pub-id><pub-id pub-id-type="pmcid">PMC5824464</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Higashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>S</given-names></name><name name-style="western"><surname>Delafontaine</surname><given-names>P</given-names></name><name name-style="western"><surname>Sukhanov</surname><given-names>S</given-names></name></person-group><article-title>IGF-1 and cardiovascular disease</article-title><source>Growth Horm IGF Res</source><year>2019</year><volume>45</volume><fpage>6</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.ghir.2019.01.002</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.ghir.2019.01.002</pub-id><pub-id pub-id-type="pmid">30735831</pub-id><pub-id pub-id-type="pmcid">PMC6504961</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hikisz</surname><given-names>P</given-names></name><name name-style="western"><surname>Bernasinska-Slomczewska</surname><given-names>J</given-names></name></person-group><article-title>Beneficial properties of bromelain</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><issue>12</issue><fpage>4313</fpage><pub-id pub-id-type="doi">10.3390/nu13124313</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/nu13124313</pub-id><pub-id pub-id-type="pmid">34959865</pub-id><pub-id pub-id-type="pmcid">PMC8709142</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hirano</surname><given-names>T</given-names></name></person-group><article-title>IL-6 in inflammation, autoimmunity and cancer</article-title><source>Int Immunol</source><year>2021</year><volume>33</volume><fpage>127</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxaa078</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/intimm/dxaa078</pub-id><pub-id pub-id-type="pmid">33337480</pub-id><pub-id pub-id-type="pmcid">PMC7799025</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hirche</surname><given-names>C</given-names></name><name name-style="western"><surname>Kreken Almeland</surname><given-names>S</given-names></name><name name-style="western"><surname>Dheansa</surname><given-names>B</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>P</given-names></name><name name-style="western"><surname>Governa</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoeksema</surname><given-names>H</given-names></name><etal/></person-group><article-title>Eschar removal by bromelain based enzymatic debridement (Nexobrid&#174;) in burns: European consensus guidelines update</article-title><source>Burns</source><year>2020</year><volume>46</volume><fpage>782</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2020.03.002</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.burns.2020.03.002</pub-id><pub-id pub-id-type="pmid">32241591</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hirsch</surname><given-names>FR</given-names></name><name name-style="western"><surname>Scagliotti</surname><given-names>GV</given-names></name><name name-style="western"><surname>Mulshine</surname><given-names>JL</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>R</given-names></name><name name-style="western"><surname>Curran</surname><given-names>WJ</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Wu</surname><given-names>YL</given-names></name><etal/></person-group><article-title>Lung cancer: current therapies and new targeted treatments</article-title><source>Lancet</source><year>2017</year><volume>389</volume><issue>10066</issue><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(16)30958-8</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/s0140-6736(16)30958-8</pub-id><pub-id pub-id-type="pmid">27574741</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hodge</surname><given-names>AL</given-names></name><name name-style="western"><surname>Baxter</surname><given-names>AA</given-names></name><name name-style="western"><surname>Poon</surname><given-names>IKH</given-names></name></person-group><article-title>Gift bags from the sentinel cells of the immune system: The diverse role of dendritic cell-derived extracellular vesicles</article-title><source>J Leukoc Biol</source><year>2022</year><volume>111</volume><fpage>903</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1002/jlb.3ru1220-801r</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/jlb.3ru1220-801r</pub-id><pub-id pub-id-type="pmid">34699107</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hoesel</surname><given-names>B</given-names></name><name name-style="western"><surname>Schmid</surname><given-names>JA</given-names></name></person-group><article-title>The complexity of NF-&#954;B signaling in inflammation and cancer</article-title><source>Mol Cancer</source><year>2013</year><volume>12</volume><fpage>86</fpage><pub-id pub-id-type="doi">10.1186/1476-4598-12-86</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/1476-4598-12-86</pub-id><pub-id pub-id-type="pmid">23915189</pub-id><pub-id pub-id-type="pmcid">PMC3750319</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Holme</surname><given-names>JA</given-names></name><name name-style="western"><surname>Vondr&#225;&#269;ek</surname><given-names>J</given-names></name><name name-style="western"><surname>Machala</surname><given-names>M</given-names></name><name name-style="western"><surname>Lagadic-Gossmann</surname><given-names>D</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>CFA</given-names></name><name name-style="western"><surname>Le Ferrec</surname><given-names>E</given-names></name><etal/></person-group><article-title>Lung cancer associated with combustion particles and fine particulate matter (PM(2.5)) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)</article-title><source>Biochem Pharmacol</source><year>2023</year><volume>216</volume><fpage>115801</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2023.115801</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.bcp.2023.115801</pub-id><pub-id pub-id-type="pmid">37696458</pub-id><pub-id pub-id-type="pmcid">PMC10543654</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hou</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Ma</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Meng</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cigarette smoke induced lung barrier dysfunction, emt, and tissue remodeling: a possible link between COPD and lung cancer</article-title><source>BioMed Res Int</source><year>2019</year><volume>2019</volume><fpage>2025636</fpage><pub-id pub-id-type="doi">10.1155/2019/2025636</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1155/2019/2025636</pub-id><pub-id pub-id-type="pmid">31341890</pub-id><pub-id pub-id-type="pmcid">PMC6613007</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hoy</surname><given-names>H</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>T</given-names></name><name name-style="western"><surname>Beck</surname><given-names>M</given-names></name></person-group><article-title>Surgical treatment of lung cancer</article-title><source>Crit Care Nurs Clin North Am</source><year>2019</year><volume>31</volume><fpage>303</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.cnc.2019.05.002</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cnc.2019.05.002</pub-id><pub-id pub-id-type="pmid">31351552</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hsieh</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Ng</surname><given-names>SC</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>RY</given-names></name><name name-style="western"><surname>Padma</surname><given-names>VV</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>WW</given-names></name></person-group><article-title>Diallyl Trisulfide (DATS) suppresses AGE-induced cardiomyocyte apoptosis by targeting ROS-mediated PKC&#948; activation</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>7</issue><fpage>2608</fpage><pub-id pub-id-type="doi">10.3390/ijms21072608</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/ijms21072608</pub-id><pub-id pub-id-type="pmid">32283691</pub-id><pub-id pub-id-type="pmcid">PMC7178155</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Su</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>C</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-&#954;B pathway</article-title><source>Biochem Cell Biol</source><year>2022</year><volume>100</volume><fpage>223</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1139/bcb-2021-0251</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1139/bcb-2021-0251</pub-id><pub-id pub-id-type="pmid">35833632</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>N</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name></person-group><article-title>Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective</article-title><source>Semin Cancer Biol</source><year>2023</year><volume>89</volume><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2023.01.006</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.semcancer.2023.01.006</pub-id><pub-id pub-id-type="pmid">36682439</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Guan</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name></person-group><article-title>MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model</article-title><source>Respir Res</source><year>2022</year><volume>23</volume><issue>1</issue><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/s12931-021-01920-8</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/s12931-021-01920-8</pub-id><pub-id pub-id-type="pmid">35042537</pub-id><pub-id pub-id-type="pmcid">PMC8764756</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Hussain</surname><given-names>MS</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><etal/></person-group><article-title>From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders</article-title><source>J Biochem Mol Toxicol</source><year>2023</year><volume>37</volume><issue>11</issue><fpage>e23482</fpage><pub-id pub-id-type="doi">10.1002/jbt.23482</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/jbt.23482</pub-id><pub-id pub-id-type="pmid">37530602</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lei</surname><given-names>B</given-names></name><etal/></person-group><article-title>Linalool induces resistance against tobacco mosaic virus in tobacco plants</article-title><source>Plant Dis</source><year>2023</year><volume>107</volume><fpage>2144</fpage><lpage>2152</lpage><pub-id pub-id-type="doi">10.1094/pdis-09-22-2246-re</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1094/pdis-09-22-2246-re</pub-id><pub-id pub-id-type="pmid">36917091</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Jin</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cigarette smoking induces aberrant N(6)-methyladenosine of DAPK2 to promote non-small cell lung cancer progression by activating NF-&#954;B pathway</article-title><source>Cancer Lett</source><year>2021</year><volume>518</volume><fpage>214</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2021.07.022</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.canlet.2021.07.022</pub-id><pub-id pub-id-type="pmid">34298122</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Jin</surname><given-names>SY</given-names></name><name name-style="western"><surname>Luo</surname><given-names>JY</given-names></name><name name-style="western"><surname>Li</surname><given-names>XM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Ma</surname><given-names>YT</given-names></name><name name-style="western"><surname>Gao</surname><given-names>XM</given-names></name><etal/></person-group><article-title>NFKB1 gene rs28362491 polymorphism is associated with the susceptibility of acute coronary syndrome</article-title><source>Biosci Rep</source><year>2019</year><volume>39</volume><issue>4</issue><fpage>BSR20182292</fpage><pub-id pub-id-type="doi">10.1042/bsr20182292</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1042/bsr20182292</pub-id><pub-id pub-id-type="pmid">30910844</pub-id><pub-id pub-id-type="pmcid">PMC6470809</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Johannessen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Boehm</surname><given-names>JS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SY</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>SR</given-names></name><name name-style="western"><surname>Wardwell</surname><given-names>L</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>LA</given-names></name><etal/></person-group><article-title>COT drives resistance to RAF inhibition through MAP kinase pathway reactivation</article-title><source>Nature</source><year>2010</year><volume>468</volume><issue>7326</issue><fpage>968</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/nature09627</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1038/nature09627</pub-id><pub-id pub-id-type="pmid">21107320</pub-id><pub-id pub-id-type="pmcid">PMC3058384</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Jomova</surname><given-names>K</given-names></name><name name-style="western"><surname>Raptova</surname><given-names>R</given-names></name><name name-style="western"><surname>Alomar</surname><given-names>SY</given-names></name><name name-style="western"><surname>Alwasel</surname><given-names>SH</given-names></name><name name-style="western"><surname>Nepovimova</surname><given-names>E</given-names></name><name name-style="western"><surname>Kuca</surname><given-names>K</given-names></name><etal/></person-group><article-title>Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging</article-title><source>Arch Toxicol</source><year>2023</year><volume>97</volume><fpage>2499</fpage><lpage>2574</lpage><pub-id pub-id-type="doi">10.1007/s00204-023-03562-9</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s00204-023-03562-9</pub-id><pub-id pub-id-type="pmid">37597078</pub-id><pub-id pub-id-type="pmcid">PMC10475008</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kanga</surname><given-names>KJW</given-names></name><name name-style="western"><surname>Kanga</surname><given-names>LHB</given-names></name><name name-style="western"><surname>Mendonca</surname><given-names>P</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>KFA</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>DT</given-names></name><name name-style="western"><surname>Reed</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Attenuative effect of diallyl trisulfide on caspase activity in TNF-&#945;-induced triple negative breast cancer cells</article-title><source>Anticancer Res</source><year>2023</year><volume>43</volume><fpage>2393</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.21873/anticanres.16407</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.21873/anticanres.16407</pub-id><pub-id pub-id-type="pmid">37247921</pub-id><pub-id pub-id-type="pmcid">PMC10791149</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kaur</surname><given-names>G</given-names></name><name name-style="western"><surname>Batra</surname><given-names>S</given-names></name></person-group><article-title>Regulation of DNA methylation signatures on NF-&#954;B and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro</article-title><source>Cell Biol Toxicol</source><year>2020</year><volume>36</volume><fpage>459</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s10565-020-09522-8</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s10565-020-09522-8</pub-id><pub-id pub-id-type="pmid">32342329</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kaur</surname><given-names>J</given-names></name><name name-style="western"><surname>Gulati</surname><given-names>M</given-names></name><name name-style="western"><surname>Corrie</surname><given-names>L</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>A</given-names></name><name name-style="western"><surname>Jha</surname><given-names>NK</given-names></name><name name-style="western"><surname>Chellappan</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Role of nucleic acid-based polymeric micelles in treating lung diseases</article-title><source>Nanomedicine</source><year>2022</year><volume>17</volume><fpage>1951</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.2217/nnm-2022-0260</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2217/nnm-2022-0260</pub-id><pub-id pub-id-type="pmid">36606499</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Khan</surname><given-names>H</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>H</given-names></name><name name-style="western"><surname>Castilho</surname><given-names>P</given-names></name><name name-style="western"><surname>Gomila</surname><given-names>AS</given-names></name><name name-style="western"><surname>D'Onofrio</surname><given-names>G</given-names></name><name name-style="western"><surname>Filosa</surname><given-names>R</given-names></name><etal/></person-group><article-title>Targeting NF-&#954;B signaling pathway in cancer by dietary polyphenols</article-title><source>Crit Rev Food Sci Nutr</source><year>2020</year><volume>60</volume><fpage>2790</fpage><lpage>2800</lpage><pub-id pub-id-type="doi">10.1080/10408398.2019.1661827</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/10408398.2019.1661827</pub-id><pub-id pub-id-type="pmid">31512490</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kim</surname><given-names>MY</given-names></name><name name-style="western"><surname>Bang</surname><given-names>E</given-names></name><name name-style="western"><surname>Hwangbo</surname><given-names>H</given-names></name><name name-style="western"><surname>Ji</surname><given-names>SY</given-names></name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><etal/></person-group><article-title>Diallyl trisulfide inhibits monosodium urate-induced NLRP3 inflammasome activation via NOX3/4-dependent mitochondrial oxidative stress in RAW 264.7 and bone marrow-derived macrophages</article-title><source>Phytomedicine</source><year>2023</year><volume>112</volume><fpage>154705</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2023.154705</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.phymed.2023.154705</pub-id><pub-id pub-id-type="pmid">36796188</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kim</surname><given-names>SL</given-names></name><name name-style="western"><surname>Choi</surname><given-names>HS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DS</given-names></name></person-group><article-title>BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells</article-title><source>Cell Commun Signal</source><year>2023</year><volume>21</volume><issue>1</issue><fpage>315</fpage><pub-id pub-id-type="doi">10.1186/s12964-023-01319-6</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/s12964-023-01319-6</pub-id><pub-id pub-id-type="pmid">37924094</pub-id><pub-id pub-id-type="pmcid">PMC10623882</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kolenda</surname><given-names>T</given-names></name><name name-style="western"><surname>Guglas</surname><given-names>K</given-names></name><name name-style="western"><surname>Kopczy&#324;ska</surname><given-names>M</given-names></name><name name-style="western"><surname>Soboci&#324;ska</surname><given-names>J</given-names></name><name name-style="western"><surname>Teresiak</surname><given-names>A</given-names></name><name name-style="western"><surname>Bli&#378;niak</surname><given-names>R</given-names></name><etal/></person-group><article-title>Good or not good: Role of miR-18a in cancer biology</article-title><source>Rep Pract Oncol Radiother</source><year>2020</year><volume>25</volume><fpage>808</fpage><lpage>819</lpage><pub-id pub-id-type="doi">10.1016/j.rpor.2020.07.006</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.rpor.2020.07.006</pub-id><pub-id pub-id-type="pmid">32884453</pub-id><pub-id pub-id-type="pmcid">PMC7451592</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kordiak</surname><given-names>J</given-names></name><name name-style="western"><surname>Bielec</surname><given-names>F</given-names></name><name name-style="western"><surname>Jab&#322;o&#324;ski</surname><given-names>S</given-names></name><name name-style="western"><surname>Pastuszak-Lewandoska</surname><given-names>D</given-names></name></person-group><article-title>Role of beta-carotene in lung cancer primary chemoprevention: a systematic review with meta-analysis and meta-regression</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><issue>7</issue><fpage>1361</fpage><pub-id pub-id-type="doi">10.3390/nu14071361</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/nu14071361</pub-id><pub-id pub-id-type="pmid">35405977</pub-id><pub-id pub-id-type="pmcid">PMC9003277</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Koriem</surname><given-names>KMM</given-names></name><name name-style="western"><surname>El-Qady</surname><given-names>SWB</given-names></name></person-group><article-title>Linalool attenuates hypothalamus proteome disturbance facilitated by methamphetamine induced neurotoxicity in rats</article-title><source>Neurotoxicology</source><year>2023</year><volume>99</volume><fpage>70</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.neuro.2023.09.007</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.neuro.2023.09.007</pub-id><pub-id pub-id-type="pmid">37729970</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Krasselt</surname><given-names>M</given-names></name><name name-style="western"><surname>Baerwald</surname><given-names>C</given-names></name></person-group><article-title>Celecoxib for the treatment of musculoskeletal arthritis</article-title><source>Expert Opin Pharmacother</source><year>2019</year><volume>20</volume><fpage>1689</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1080/14656566.2019.1645123</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/14656566.2019.1645123</pub-id><pub-id pub-id-type="pmid">31339385</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Krizan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Johar</surname><given-names>O</given-names></name></person-group><article-title>Narcissistic rage revisited</article-title><source>J Pers Soc Psychol</source><year>2015</year><volume>108</volume><fpage>784</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1037/pspp0000013</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1037/pspp0000013</pub-id><pub-id pub-id-type="pmid">25545840</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kumar</surname><given-names>V</given-names></name><name name-style="western"><surname>Mangla</surname><given-names>B</given-names></name><name name-style="western"><surname>Javed</surname><given-names>S</given-names></name><name name-style="western"><surname>Ahsan</surname><given-names>W</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name><name name-style="western"><surname>Garg</surname><given-names>V</given-names></name><etal/></person-group><article-title>Bromelain: a review of its mechanisms, pharmacological effects and potential applications</article-title><source>Food Funct</source><year>2023</year><volume>14</volume><fpage>8101</fpage><lpage>8128</lpage><pub-id pub-id-type="doi">10.1039/d3fo01060k</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1039/d3fo01060k</pub-id><pub-id pub-id-type="pmid">37650738</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Kunnumakkara</surname><given-names>AB</given-names></name><name name-style="western"><surname>Shabnam</surname><given-names>B</given-names></name><name name-style="western"><surname>Girisa</surname><given-names>S</given-names></name><name name-style="western"><surname>Harsha</surname><given-names>C</given-names></name><name name-style="western"><surname>Banik</surname><given-names>K</given-names></name><name name-style="western"><surname>Devi</surname><given-names>TB</given-names></name><etal/></person-group><article-title>Inflammation, NF-&#954;B, and chronic diseases: how are they linked?</article-title><source>Crit Rev Immunol</source><year>2020</year><volume>40</volume><issue>1</issue><fpage>1</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1615/CritRevImmunol.2020033210</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1615/CritRevImmunol.2020033210</pub-id><pub-id pub-id-type="pmid">32421977</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lalle</surname><given-names>G</given-names></name><name name-style="western"><surname>Twardowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Grinberg-Bleyer</surname><given-names>Y</given-names></name></person-group><article-title>NF-&#954;B in cancer immunity: friend or foe?</article-title><source>Cells</source><year>2021</year><volume>10</volume><issue>2</issue><fpage>355</fpage><pub-id pub-id-type="doi">10.3390/cells10020355</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/cells10020355</pub-id><pub-id pub-id-type="pmid">33572260</pub-id><pub-id pub-id-type="pmcid">PMC7914614</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lawrence</surname><given-names>T</given-names></name></person-group><article-title>Macrophages and NF-&#954;B in cancer</article-title><source>Curr Top Microbiol Immunol</source><year>2011</year><volume>349</volume><fpage>171</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1007/82_2010_100</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/82_2010_100</pub-id><pub-id pub-id-type="pmid">21080151</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lee</surname><given-names>E</given-names></name><name name-style="western"><surname>Kazerooni</surname><given-names>EA</given-names></name></person-group><article-title>Lung cancer screening</article-title><source>Semin Respir Crit Care Med</source><year>2022</year><volume>43</volume><fpage>839</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1055/s-0042-1757885</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1055/s-0042-1757885</pub-id><pub-id pub-id-type="pmid">36442474</pub-id></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lelis</surname><given-names>DF</given-names></name><name name-style="western"><surname>Freitas</surname><given-names>DF</given-names></name><name name-style="western"><surname>Machado</surname><given-names>AS</given-names></name><name name-style="western"><surname>Crespo</surname><given-names>TS</given-names></name><name name-style="western"><surname>Santos</surname><given-names>SHS</given-names></name></person-group><article-title>Angiotensin-(1-7), adipokines and inflammation</article-title><source>Metabolism</source><year>2019</year><volume>95</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2019.03.006</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.metabol.2019.03.006</pub-id><pub-id pub-id-type="pmid">30905634</pub-id></element-citation></ref><ref id="R115"><label>115</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Leone</surname><given-names>A</given-names></name><name name-style="western"><surname>Caroppo</surname><given-names>A</given-names></name><name name-style="western"><surname>Manni</surname><given-names>A</given-names></name><name name-style="western"><surname>Siciliano</surname><given-names>P</given-names></name></person-group><article-title>Vision-based road rage detection framework in automotive safety applications</article-title><source>Sensors (Basel)</source><year>2021</year><volume>21</volume><issue>9</issue><fpage>2942</fpage><pub-id pub-id-type="doi">10.3390/s21092942</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/s21092942</pub-id><pub-id pub-id-type="pmid">33922146</pub-id><pub-id pub-id-type="pmcid">PMC8122704</pub-id></element-citation></ref><ref id="R116"><label>116</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Leung</surname><given-names>WS</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>WW</given-names></name><name name-style="western"><surname>Ju</surname><given-names>DT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TD</given-names></name><name name-style="western"><surname>Shao-Tsu Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Ho</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Protective effects of diallyl trisulfide (DATS) against doxorubicin-induced inflammation and oxidative stress in the brain of rats</article-title><source>Free Radic Biol Med</source><year>2020</year><volume>160</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.07.018</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2020.07.018</pub-id><pub-id pub-id-type="pmid">32745770</pub-id></element-citation></ref><ref id="R117"><label>117</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Levenberg</surname><given-names>K</given-names></name><name name-style="western"><surname>Edris</surname><given-names>W</given-names></name><name name-style="western"><surname>Levine</surname><given-names>M</given-names></name><name name-style="western"><surname>George</surname><given-names>DR</given-names></name></person-group><article-title>Considering a potential role of linalool as a mood stabilizer for bipolar disorder</article-title><source>Curr Pharm Des</source><year>2020</year><volume>26</volume><fpage>5128</fpage><lpage>5133</lpage><pub-id pub-id-type="doi">10.2174/1381612826666200724160742</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1381612826666200724160742</pub-id><pub-id pub-id-type="pmid">32713332</pub-id></element-citation></ref><ref id="R118"><label>118</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZT</given-names></name></person-group><article-title>Genetic Association between NFKBIA and NFKB1 gene polymorphisms and the susceptibility to head and neck cancer: a meta-analysis</article-title><source>Dis Markers</source><year>2019</year><volume>2019</volume><fpage>6523837</fpage><pub-id pub-id-type="doi">10.1155/2019/6523837</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1155/2019/6523837</pub-id><pub-id pub-id-type="pmid">31612070</pub-id><pub-id pub-id-type="pmcid">PMC6757245</pub-id></element-citation></ref><ref id="R119"><label>119</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Mohammadtursun</surname><given-names>N</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Dong</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name></person-group><article-title>Curcumin inhibits cigarette smoke-induced inflammation via modulating the PPAR&#947;-NF-&#954;B signaling pathway</article-title><source>Food Funct</source><year>2019</year><volume>10</volume><fpage>7983</fpage><lpage>7994</lpage><pub-id pub-id-type="doi">10.1039/c9fo02159k</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1039/c9fo02159k</pub-id><pub-id pub-id-type="pmid">31773117</pub-id></element-citation></ref><ref id="R120"><label>120</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Lu</surname><given-names>X</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>6350</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-34209-5</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1038/s41467-022-34209-5</pub-id><pub-id pub-id-type="pmid">36289222</pub-id><pub-id pub-id-type="pmcid">PMC9605963</pub-id></element-citation></ref><ref id="R121"><label>121</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lin</surname><given-names>KH</given-names></name><name name-style="western"><surname>Ng</surname><given-names>SC</given-names></name><name name-style="western"><surname>Lu</surname><given-names>SY</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>SH</given-names></name><name name-style="western"><surname>Su</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Diallyl trisulfide (DATS) protects cardiac cells against advanced glycation end-product-induced apoptosis by enhancing FoxO3A-dependent upregulation of miRNA-210</article-title><source>J Nutr Biochem</source><year>2024</year><volume>125</volume><fpage>109567</fpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2024.109567</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.jnutbio.2024.109567</pub-id><pub-id pub-id-type="pmid">38185348</pub-id></element-citation></ref><ref id="R122"><label>122</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lin</surname><given-names>S</given-names></name><name name-style="western"><surname>Mei</surname><given-names>W</given-names></name><name name-style="western"><surname>Lai</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Weng</surname><given-names>H</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cigarette smoking promotes keratinocyte malignancy via generation of cancer stem-like cells</article-title><source>J Cancer</source><year>2021</year><volume>12</volume><fpage>1085</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.7150/jca.50746</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.7150/jca.50746</pub-id><pub-id pub-id-type="pmid">33442406</pub-id><pub-id pub-id-type="pmcid">PMC7797662</pub-id></element-citation></ref><ref id="R123"><label>123</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>SW</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>JM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>DC</given-names></name><etal/></person-group><article-title>MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer</article-title><source>Theranostics</source><year>2021</year><volume>11</volume><fpage>4122</fpage><lpage>4136</lpage><pub-id pub-id-type="doi">10.7150/thno.53558</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.7150/thno.53558</pub-id><pub-id pub-id-type="pmid">33754052</pub-id><pub-id pub-id-type="pmcid">PMC7977464</pub-id></element-citation></ref><ref id="R124"><label>124</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Liu</surname><given-names>MY</given-names></name><name name-style="western"><surname>Ju</surname><given-names>YN</given-names></name><name name-style="western"><surname>Jia</surname><given-names>BW</given-names></name><name name-style="western"><surname>Sun</surname><given-names>XK</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>HY</given-names></name><etal/></person-group><article-title>Inhibition of DNA methylation attenuates lung ischemia-reperfusion injury after lung transplantation</article-title><source>J Int Med Res</source><year>2023</year><volume>51</volume><issue>2</issue><fpage>3000605231153587</fpage><pub-id pub-id-type="doi">10.1177/03000605231153587</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1177/03000605231153587</pub-id><pub-id pub-id-type="pmid">36756846</pub-id><pub-id pub-id-type="pmcid">PMC9912569</pub-id></element-citation></ref><ref id="R125"><label>125</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Long</surname><given-names>J</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Baranova</surname><given-names>A</given-names></name><name name-style="western"><surname>Cao</surname><given-names>H</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia</article-title><source>Psychiatry Res</source><year>2022</year><volume>312</volume><fpage>114588</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2022.114588</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.psychres.2022.114588</pub-id><pub-id pub-id-type="pmid">35524996</pub-id></element-citation></ref><ref id="R126"><label>126</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P</given-names></name><name name-style="western"><surname>Xue</surname><given-names>J</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Involvement of HIF-1&#945;-regulated miR-21, acting via the Akt/NF-&#954;B pathway, in malignant transformation of HBE cells induced by cigarette smoke extract</article-title><source>Toxicol Lett</source><year>2018</year><volume>289</volume><fpage>14</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2018.02.027</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.toxlet.2018.02.027</pub-id><pub-id pub-id-type="pmid">29501572</pub-id></element-citation></ref><ref id="R127"><label>127</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Luna</surname><given-names>P</given-names></name><name name-style="western"><surname>Fernanda P&#233;rez</surname><given-names>M</given-names></name><name name-style="western"><surname>Castellar-Lopez</surname><given-names>J</given-names></name><name name-style="western"><surname>Chang</surname><given-names>A</given-names></name><name name-style="western"><surname>Montoya</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bustamante</surname><given-names>J</given-names></name><etal/></person-group><article-title>Potential of Angiotensin-(1-7) in COVID-19 Treatment</article-title><source>Curr Protein Pept Sci</source><year>2023</year><volume>24</volume><issue>1</issue><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.2174/1389203724666221130140416</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1389203724666221130140416</pub-id><pub-id pub-id-type="pmid">36453502</pub-id></element-citation></ref><ref id="R128"><label>128</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Qu</surname><given-names>C</given-names></name><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name></person-group><article-title>Linalool inhibits cigarette smoke-induced lung inflammation by inhibiting NF-&#954;B activation</article-title><source>Int Immunopharmacol</source><year>2015</year><volume>29</volume><fpage>708</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2015.09.005</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.intimp.2015.09.005</pub-id><pub-id pub-id-type="pmid">26432179</pub-id></element-citation></ref><ref id="R129"><label>129</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chu</surname><given-names>S</given-names></name></person-group><article-title>Cigarette and IL-17A synergistically induce bronchial epithelial-mesenchymal transition via activating IL-17R/NF-&#954;B signaling</article-title><source>BMC Pulm Med</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/s12890-020-1057-6</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/s12890-020-1057-6</pub-id><pub-id pub-id-type="pmid">32000730</pub-id><pub-id pub-id-type="pmcid">PMC6993491</pub-id></element-citation></ref><ref id="R130"><label>130</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>MacLaren</surname><given-names>G</given-names></name></person-group><article-title>Rage, rage against the dying of the light? Intensive care for the very elderly</article-title><source>Minerva Anestesiol</source><year>2015</year><volume>81</volume><fpage>709</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">25653149</pub-id></element-citation></ref><ref id="R131"><label>131</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Majumder</surname><given-names>D</given-names></name><name name-style="western"><surname>Debnath</surname><given-names>R</given-names></name><name name-style="western"><surname>Nath</surname><given-names>P</given-names></name><name name-style="western"><surname>Libin Kumar</surname><given-names>KV</given-names></name><name name-style="western"><surname>Debnath</surname><given-names>M</given-names></name><name name-style="western"><surname>Tribedi</surname><given-names>P</given-names></name><etal/></person-group><article-title>Bromelain and Olea europaea (L.) leaf extract mediated alleviation of benzo(a)pyrene induced lung cancer through Nrf2 and NF&#954;B pathway</article-title><source>Environ Sci Pollut Res Int</source><year>2021</year><volume>28</volume><fpage>47306</fpage><lpage>47326</lpage><pub-id pub-id-type="doi">10.1007/s11356-021-13803-y</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s11356-021-13803-y</pub-id><pub-id pub-id-type="pmid">33893581</pub-id></element-citation></ref><ref id="R132"><label>132</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Malyla</surname><given-names>V</given-names></name><name name-style="western"><surname>Paudel</surname><given-names>KR</given-names></name><name name-style="western"><surname>De Rubis</surname><given-names>G</given-names></name><name name-style="western"><surname>Hansbro</surname><given-names>NG</given-names></name><name name-style="western"><surname>Hansbro</surname><given-names>PM</given-names></name><name name-style="western"><surname>Dua</surname><given-names>K</given-names></name></person-group><article-title>Cigarette smoking induces lung cancer tumorigenesis via upregulation of the WNT/&#946;-catenin signaling pathway</article-title><source>Life Sci</source><year>2023</year><volume>326</volume><fpage>121787</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2023.121787</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.lfs.2023.121787</pub-id><pub-id pub-id-type="pmid">37209867</pub-id></element-citation></ref><ref id="R133"><label>133</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Marciscano</surname><given-names>AE</given-names></name><name name-style="western"><surname>Anandasabapathy</surname><given-names>N</given-names></name></person-group><article-title>The role of dendritic cells in cancer and anti-tumor immunity</article-title><source>Semin Immunol</source><year>2021</year><volume>52</volume><fpage>101481</fpage><pub-id pub-id-type="doi">10.1016/j.smim.2021.101481</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.smim.2021.101481</pub-id><pub-id pub-id-type="pmid">34023170</pub-id><pub-id pub-id-type="pmcid">PMC8545750</pub-id></element-citation></ref><ref id="R134"><label>134</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Martey</surname><given-names>CA</given-names></name><name name-style="western"><surname>Pollock</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Turner</surname><given-names>CK</given-names></name><name name-style="western"><surname>O'Reilly</surname><given-names>KM</given-names></name><name name-style="western"><surname>Baglole</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2004</year><volume>287</volume><fpage>L981</fpage><lpage>L991</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00239.2003</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1152/ajplung.00239.2003</pub-id><pub-id pub-id-type="pmid">15234907</pub-id></element-citation></ref><ref id="R135"><label>135</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Maurer</surname><given-names>HR</given-names></name></person-group><article-title>Bromelain: biochemistry, pharmacology and medical use</article-title><source>Cell Mol Life Sci</source><year>2001</year><volume>58</volume><fpage>1234</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1007/pl00000936</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/pl00000936</pub-id><pub-id pub-id-type="pmid">11577981</pub-id><pub-id pub-id-type="pmcid">PMC11337410</pub-id></element-citation></ref><ref id="R136"><label>136</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Medina</surname><given-names>D</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>AC</given-names></name></person-group><article-title>Angiotensin-(1-7): Translational avenues in cardiovascular control</article-title><source>Am J Hypertens</source><year>2019</year><volume>32</volume><fpage>1133</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1093/ajh/hpz146</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/ajh/hpz146</pub-id><pub-id pub-id-type="pmid">31602467</pub-id><pub-id pub-id-type="pmcid">PMC6856625</pub-id></element-citation></ref><ref id="R137"><label>137</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Mei</surname><given-names>D</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W</given-names></name><name name-style="western"><surname>Gan</surname><given-names>PXL</given-names></name><name name-style="western"><surname>Tran</surname><given-names>QTN</given-names></name><name name-style="western"><surname>Chan</surname><given-names>C</given-names></name><name name-style="western"><surname>Heng</surname><given-names>CKM</given-names></name><etal/></person-group><article-title>Angiotensin II type-2 receptor activation in alveolar macrophages mediates protection against cigarette smoke-induced chronic obstructive pulmonary disease</article-title><source>Pharmacol Res</source><year>2022</year><volume>184</volume><fpage>106469</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106469</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106469</pub-id><pub-id pub-id-type="pmid">36167278</pub-id></element-citation></ref><ref id="R138"><label>138</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Millet</surname><given-names>P</given-names></name><name name-style="western"><surname>McCall</surname><given-names>C</given-names></name><name name-style="western"><surname>Yoza</surname><given-names>B</given-names></name></person-group><article-title>RelB: an outlier in leukocyte biology</article-title><source>J Leukoc Biol</source><year>2013</year><volume>94</volume><fpage>941</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1189/jlb.0513305</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1189/jlb.0513305</pub-id><pub-id pub-id-type="pmid">23922380</pub-id><pub-id pub-id-type="pmcid">PMC3800064</pub-id></element-citation></ref><ref id="R139"><label>139</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Min</surname><given-names>HY</given-names></name><name name-style="western"><surname>Boo</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Jang</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Yun</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>70936</fpage><lpage>70947</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.12342</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.18632/oncotarget.12342</pub-id><pub-id pub-id-type="pmid">27708216</pub-id><pub-id pub-id-type="pmcid">PMC5342599</pub-id></element-citation></ref><ref id="R140"><label>140</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Mockenhaupt</surname><given-names>K</given-names></name><name name-style="western"><surname>Gonsiewski</surname><given-names>A</given-names></name><name name-style="western"><surname>Kordula</surname><given-names>T</given-names></name></person-group><article-title>RelB and neuroinflammation</article-title><source>Cells</source><year>2021</year><volume>10</volume><issue>7</issue><fpage>1609</fpage><pub-id pub-id-type="doi">10.3390/cells10071609</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/cells10071609</pub-id><pub-id pub-id-type="pmid">34198987</pub-id><pub-id pub-id-type="pmcid">PMC8307460</pub-id></element-citation></ref><ref id="R141"><label>141</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Moorthy</surname><given-names>B</given-names></name><name name-style="western"><surname>Chu</surname><given-names>C</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>DJ</given-names></name></person-group><article-title>Polycyclic aromatic hydrocarbons: from metabolism to lung cancer</article-title><source>Toxicol Sci</source><year>2015</year><volume>145</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfv040</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/toxsci/kfv040</pub-id><pub-id pub-id-type="pmid">25911656</pub-id><pub-id pub-id-type="pmcid">PMC4408964</pub-id></element-citation></ref><ref id="R142"><label>142</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Nagah</surname><given-names>A</given-names></name><name name-style="western"><surname>Amer</surname><given-names>A</given-names></name></person-group><article-title>Different mechanisms of cigarette smoking-induced lung cancer</article-title><source>Acta Biotheor</source><year>2021</year><volume>69</volume><fpage>37</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1007/s10441-020-09394-9</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s10441-020-09394-9</pub-id><pub-id pub-id-type="pmid">32979115</pub-id></element-citation></ref><ref id="R143"><label>143</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Nagah</surname><given-names>A</given-names></name><name name-style="western"><surname>Amer</surname><given-names>A</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>The effect of cigarette smoking on lung cancer evolution</article-title><source>Math Biosci Eng</source><year>2019</year><volume>16</volume><fpage>7771</fpage><lpage>7788</lpage><pub-id pub-id-type="doi">10.3934/mbe.2019390</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3934/mbe.2019390</pub-id><pub-id pub-id-type="pmid">31698639</pub-id></element-citation></ref><ref id="R144"><label>144</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Navarro</surname><given-names>HI</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>A</given-names></name><name name-style="western"><surname>Lefaudeux</surname><given-names>D</given-names></name><name name-style="western"><surname>Chia</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Vong</surname><given-names>L</given-names></name><etal/></person-group><article-title>RelB-deficient autoinflammatory pathology presents as interferonopathy, but in mice is interferon-independent</article-title><source>J Allergy Clin Immunol</source><year>2023</year><volume>152</volume><fpage>1261</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2023.06.024</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.jaci.2023.06.024</pub-id><pub-id pub-id-type="pmid">37460023</pub-id><pub-id pub-id-type="pmcid">PMC10858800</pub-id></element-citation></ref><ref id="R145"><label>145</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ou</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-&#954;B-MyD88 signalling pathway and NLRP3 inflammasome</article-title><source>Int Immunopharmacol</source><year>2022</year><volume>103</volume><fpage>108445</fpage><pub-id pub-id-type="doi">10.1016/j.intimp.2021.108445</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.intimp.2021.108445</pub-id><pub-id pub-id-type="pmid">34998273</pub-id></element-citation></ref><ref id="R146"><label>146</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Owoyele</surname><given-names>BV</given-names></name><name name-style="western"><surname>Bakare</surname><given-names>AO</given-names></name><name name-style="western"><surname>Ologe</surname><given-names>MO</given-names></name></person-group><article-title>Bromelain: a review on its potential as a therapy for the management of Covid-19</article-title><source>Niger J Physiol Sci</source><year>2020</year><volume>35</volume><issue>1</issue><fpage>10</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">33084621</pub-id></element-citation></ref><ref id="R147"><label>147</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>R</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><etal/></person-group><article-title>FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2/angiotensin-(1-7) axis in mice</article-title><source>Cell Metab</source><year>2018</year><volume>27</volume><fpage>1323</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.002</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.002</pub-id><pub-id pub-id-type="pmid">29706566</pub-id></element-citation></ref><ref id="R148"><label>148</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Panchal</surname><given-names>NK</given-names></name><name name-style="western"><surname>Prince Sabina</surname><given-names>E</given-names></name></person-group><article-title>Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities</article-title><source>Food Chem Toxicol</source><year>2023</year><volume>172</volume><fpage>113598</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2022.113598</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.fct.2022.113598</pub-id><pub-id pub-id-type="pmid">36608735</pub-id></element-citation></ref><ref id="R149"><label>149</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Papageorgiou</surname><given-names>N</given-names></name><name name-style="western"><surname>Zacharia</surname><given-names>E</given-names></name><name name-style="western"><surname>Briasoulis</surname><given-names>A</given-names></name><name name-style="western"><surname>Charakida</surname><given-names>M</given-names></name><name name-style="western"><surname>Tousoulis</surname><given-names>D</given-names></name></person-group><article-title>Celecoxib for the treatment of atherosclerosis</article-title><source>Expert Opin Investig Drugs</source><year>2016</year><volume>25</volume><fpage>619</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1517/13543784.2016.1161756</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1517/13543784.2016.1161756</pub-id><pub-id pub-id-type="pmid">26940257</pub-id></element-citation></ref><ref id="R150"><label>150</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Petit</surname><given-names>P</given-names></name><name name-style="western"><surname>Ma&#238;tre</surname><given-names>A</given-names></name><name name-style="western"><surname>Persoons</surname><given-names>R</given-names></name><name name-style="western"><surname>Bicout</surname><given-names>DJ</given-names></name></person-group><article-title>Lung cancer risk assessment for workers exposed to polycyclic aromatic hydrocarbons in various industries</article-title><source>Environ Int</source><year>2019</year><volume>124</volume><fpage>109</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.12.058</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.envint.2018.12.058</pub-id><pub-id pub-id-type="pmid">30641254</pub-id></element-citation></ref><ref id="R151"><label>151</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Pitt</surname><given-names>JM</given-names></name><name name-style="western"><surname>Andr&#233;</surname><given-names>F</given-names></name><name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></name><name name-style="western"><surname>Soria</surname><given-names>JC</given-names></name><name name-style="western"><surname>Eggermont</surname><given-names>A</given-names></name><name name-style="western"><surname>Kroemer</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dendritic cell-derived exosomes for cancer therapy</article-title><source>J Clin Invest</source><year>2016</year><volume>126</volume><fpage>1224</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1172/jci81137</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1172/jci81137</pub-id><pub-id pub-id-type="pmid">27035813</pub-id><pub-id pub-id-type="pmcid">PMC4811123</pub-id></element-citation></ref><ref id="R152"><label>152</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Preciado</surname><given-names>D</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><name name-style="western"><surname>Wuertz</surname><given-names>B</given-names></name><name name-style="western"><surname>Rose</surname><given-names>M</given-names></name></person-group><article-title>Cigarette smoke activates NF kappa B and induces Muc5b expression in mouse middle ear cells</article-title><source>Laryngoscope</source><year>2008</year><volume>118</volume><fpage>464</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1097/MLG.0b013e31815aedc7</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1097/MLG.0b013e31815aedc7</pub-id><pub-id pub-id-type="pmid">18091336</pub-id><pub-id pub-id-type="pmcid">PMC2692718</pub-id></element-citation></ref><ref id="R153"><label>153</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Priji&#263;</surname><given-names>&#381;</given-names></name><name name-style="western"><surname>Igi&#263;</surname><given-names>R</given-names></name></person-group><article-title>Cigarette smoking and medical students</article-title><source>J BUON</source><year>2021</year><volume>26</volume><fpage>1709</fpage><lpage>1718</lpage><pub-id pub-id-type="pmid">34761573</pub-id></element-citation></ref><ref id="R154"><label>154</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Puccinelli</surname><given-names>MT</given-names></name><name name-style="western"><surname>Stan</surname><given-names>SD</given-names></name></person-group><article-title>Dietary bioactive diallyl trisulfide in cancer prevention and treatment</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><issue>8</issue><fpage>1645</fpage><pub-id pub-id-type="doi">10.3390/ijms18081645</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/ijms18081645</pub-id><pub-id pub-id-type="pmid">28788092</pub-id><pub-id pub-id-type="pmcid">PMC5578035</pub-id></element-citation></ref><ref id="R155"><label>155</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Cigarette smoking induces the activation of RIP2/caspase-12/NF-&#954;B axis in oral squamous cell carcinoma</article-title><source>PeerJ</source><year>2022</year><volume>10</volume><fpage>e14330</fpage><pub-id pub-id-type="doi">10.7717/peerj.14330</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.7717/peerj.14330</pub-id><pub-id pub-id-type="pmid">36353608</pub-id><pub-id pub-id-type="pmcid">PMC9639427</pub-id></element-citation></ref><ref id="R156"><label>156</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Qiu</surname><given-names>F</given-names></name><name name-style="western"><surname>Liang</surname><given-names>CL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Hou</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><issue>1</issue><fpage>268</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.13613</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.18632/oncotarget.13613</pub-id><pub-id pub-id-type="pmid">27902485</pub-id><pub-id pub-id-type="pmcid">PMC5352117</pub-id></element-citation></ref><ref id="R157"><label>157</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Qu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Diallyl trisulfide inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer via modulating gut microbiota and the PPAR&#947;/NF-&#954;B pathway</article-title><source>Food Funct</source><year>2024</year><volume>15</volume><issue>1</issue><fpage>158</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1039/d3fo03914e</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1039/d3fo03914e</pub-id><pub-id pub-id-type="pmid">38086660</pub-id></element-citation></ref><ref id="R158"><label>158</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rahimi</surname><given-names>O</given-names></name><name name-style="western"><surname>Melo</surname><given-names>AC</given-names></name><name name-style="western"><surname>Westwood</surname><given-names>B</given-names></name><name name-style="western"><surname>Grier</surname><given-names>RDM</given-names></name><name name-style="western"><surname>Tallant</surname><given-names>EA</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>PE</given-names></name></person-group><article-title>Angiotensin-(1-7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanisms</article-title><source>Peptides</source><year>2022</year><volume>152</volume><fpage>170784</fpage><pub-id pub-id-type="doi">10.1016/j.peptides.2022.170784</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.peptides.2022.170784</pub-id><pub-id pub-id-type="pmid">35288251</pub-id></element-citation></ref><ref id="R159"><label>159</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rasmussen</surname><given-names>KG</given-names></name></person-group><article-title>Rage against the (ECT) machine</article-title><source>J ECT</source><year>2015</year><volume>31</volume><issue>1</issue><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1097/yct.0000000000000171</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1097/yct.0000000000000171</pub-id><pub-id pub-id-type="pmid">25181022</pub-id></element-citation></ref><ref id="R160"><label>160</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rastrick</surname><given-names>JM</given-names></name><name name-style="western"><surname>Stevenson</surname><given-names>CS</given-names></name><name name-style="western"><surname>Eltom</surname><given-names>S</given-names></name><name name-style="western"><surname>Grace</surname><given-names>M</given-names></name><name name-style="western"><surname>Davies</surname><given-names>M</given-names></name><name name-style="western"><surname>Kilty</surname><given-names>I</given-names></name><etal/></person-group><article-title>Cigarette smoke induced airway inflammation is independent of NF-&#954;B signalling</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>e54128</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0054128</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0054128</pub-id><pub-id pub-id-type="pmid">23349803</pub-id><pub-id pub-id-type="pmcid">PMC3551940</pub-id></element-citation></ref><ref id="R161"><label>161</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Ratovitski</surname><given-names>EA</given-names></name></person-group><article-title>LKB1/PEA3/&#916;Np63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure</article-title><source>oxidative medicine and cellular longevity</source><year>2010</year><volume>3</volume><fpage>878947</fpage><pub-id pub-id-type="doi">10.4161/oxim.3.5.13108</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.4161/oxim.3.5.13108</pub-id><pub-id pub-id-type="pmcid">PMC3154041</pub-id><pub-id pub-id-type="pmid">21150337</pub-id></element-citation></ref><ref id="R162"><label>162</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rauf</surname><given-names>A</given-names></name><name name-style="western"><surname>Abu-Izneid</surname><given-names>T</given-names></name><name name-style="western"><surname>Thiruvengadam</surname><given-names>M</given-names></name><name name-style="western"><surname>Imran</surname><given-names>M</given-names></name><name name-style="western"><surname>Olatunde</surname><given-names>A</given-names></name><name name-style="western"><surname>Shariati</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Garlic (Allium sativum L.): its chemistry, nutritional composition, toxicity, and anticancer properties</article-title><source>Curr Top Med Chem</source><year>2022</year><volume>22</volume><fpage>957</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.2174/1568026621666211105094939</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/1568026621666211105094939</pub-id><pub-id pub-id-type="pmid">34749610</pub-id></element-citation></ref><ref id="R163"><label>163</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rioux</surname><given-names>N</given-names></name><name name-style="western"><surname>Castonguay</surname><given-names>A</given-names></name></person-group><article-title>The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB</article-title><source>Carcinogenesis</source><year>2000</year><volume>21</volume><fpage>1745</fpage><lpage>1751</lpage><pub-id pub-id-type="doi">10.1093/carcin/21.9.1745</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/carcin/21.9.1745</pub-id><pub-id pub-id-type="pmid">10964107</pub-id></element-citation></ref><ref id="R164"><label>164</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rivera</surname><given-names>GA</given-names></name><name name-style="western"><surname>Wakelee</surname><given-names>H</given-names></name></person-group><article-title>Lung cancer in never smokers</article-title><source>Adv Exp Med Biol</source><year>2016</year><volume>893</volume><fpage>43</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-24223-1_3</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/978-3-319-24223-1_3</pub-id><pub-id pub-id-type="pmid">26667338</pub-id></element-citation></ref><ref id="R165"><label>165</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rohrer</surname><given-names>J</given-names></name><name name-style="western"><surname>Wuertz</surname><given-names>BR</given-names></name><name name-style="western"><surname>Ondrey</surname><given-names>F</given-names></name></person-group><article-title>Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells</article-title><source>Laryngoscope</source><year>2010</year><volume>120</volume><fpage>1609</fpage><lpage>1613</lpage><pub-id pub-id-type="doi">10.1002/lary.20972</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/lary.20972</pub-id><pub-id pub-id-type="pmid">20564670</pub-id></element-citation></ref><ref id="R166"><label>166</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Rojas-Quintero</surname><given-names>J</given-names></name><name name-style="western"><surname>Laucho-Contreras</surname><given-names>ME</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Fucci</surname><given-names>QA</given-names></name><name name-style="western"><surname>Burkett</surname><given-names>PR</given-names></name><name name-style="western"><surname>Kim</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice</article-title><source>JCI Insight</source><year>2023</year><volume>8</volume><issue>6</issue><fpage>e130771</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.130771</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1172/jci.insight.130771</pub-id><pub-id pub-id-type="pmid">36787195</pub-id><pub-id pub-id-type="pmcid">PMC10070105</pub-id></element-citation></ref><ref id="R167"><label>167</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Saba</surname><given-names>R</given-names></name><name name-style="western"><surname>Halytskyy</surname><given-names>O</given-names></name><name name-style="western"><surname>Saleem</surname><given-names>N</given-names></name><name name-style="western"><surname>Oliff</surname><given-names>IA</given-names></name></person-group><article-title>Buccal Epithelium, cigarette smoking, and lung cancer: review of the literature</article-title><source>Oncology</source><year>2017</year><volume>93</volume><fpage>347</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1159/000479796</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1159/000479796</pub-id><pub-id pub-id-type="pmid">28889127</pub-id></element-citation></ref><ref id="R168"><label>168</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sanders</surname><given-names>NT</given-names></name><name name-style="western"><surname>Dutson</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Durrant</surname><given-names>JW</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wilcox</surname><given-names>SH</given-names></name><name name-style="western"><surname>Winden</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Cigarette smoke extract (CSE) induces RAGE-mediated inflammation in the Ca9-22 gingival carcinoma epithelial cell line</article-title><source>Arch Oral Biol</source><year>2017</year><volume>80</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.archoralbio.2017.03.021</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.archoralbio.2017.03.021</pub-id><pub-id pub-id-type="pmid">28399471</pub-id></element-citation></ref><ref id="R169"><label>169</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Seet</surname><given-names>LF</given-names></name><name name-style="western"><surname>Toh</surname><given-names>LZ</given-names></name><name name-style="western"><surname>Chu</surname><given-names>SWL</given-names></name><name name-style="western"><surname>Wong</surname><given-names>TT</given-names></name></person-group><article-title>RelB regulates basal and proinflammatory induction of conjunctival CCL2</article-title><source>Ocul Immunol Inflamm</source><year>2021</year><volume>29</volume><issue>1</issue><fpage>29</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1080/09273948.2019.1662060</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/09273948.2019.1662060</pub-id><pub-id pub-id-type="pmid">31618101</pub-id></element-citation></ref><ref id="R170"><label>170</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Shishodia</surname><given-names>S</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group><article-title>Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><fpage>5004</fpage><lpage>5012</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.Can-04-0206</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1158/0008-5472.Can-04-0206</pub-id><pub-id pub-id-type="pmid">15256475</pub-id></element-citation></ref><ref id="R171"><label>171</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Shreves</surname><given-names>AH</given-names></name><name name-style="western"><surname>Buller</surname><given-names>ID</given-names></name><name name-style="western"><surname>Chase</surname><given-names>E</given-names></name><name name-style="western"><surname>Creutzfeldt</surname><given-names>H</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>JA</given-names></name><name name-style="western"><surname>Graubard</surname><given-names>BI</given-names></name><etal/></person-group><article-title>Geographic patterns in U.S. lung cancer mortality and cigarette smoking</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2023</year><volume>32</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.Epi-22-0253</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1158/1055-9965.Epi-22-0253</pub-id><pub-id pub-id-type="pmid">36413442</pub-id><pub-id pub-id-type="pmcid">PMC9905286</pub-id></element-citation></ref><ref id="R172"><label>172</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Singh</surname><given-names>A</given-names></name><name name-style="western"><surname>Kamal</surname><given-names>R</given-names></name><name name-style="western"><surname>Ahamed</surname><given-names>I</given-names></name><name name-style="western"><surname>Wagh</surname><given-names>M</given-names></name><name name-style="western"><surname>Bihari</surname><given-names>V</given-names></name><name name-style="western"><surname>Sathian</surname><given-names>B</given-names></name><etal/></person-group><article-title>PAH exposure-associated lung cancer: an updated meta-analysis</article-title><source>Occup Med (Lond)</source><year>2018</year><volume>68</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1093/occmed/kqy049</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/occmed/kqy049</pub-id><pub-id pub-id-type="pmid">29579260</pub-id></element-citation></ref><ref id="R173"><label>173</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Singla</surname><given-names>N</given-names></name><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Kulshrestha</surname><given-names>R</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Purohit</surname><given-names>M</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>BG</given-names></name><name name-style="western"><surname>Dua</surname><given-names>K</given-names></name><name name-style="western"><surname>Ali</surname><given-names>MK</given-names></name><name name-style="western"><surname>Dave</surname><given-names>P</given-names></name></person-group><article-title>Introduction to epigenetics</article-title><source>Targeting epigenetics in inflammatory lung diseases</source><year>2023</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer</publisher-name><fpage>17</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1007/978-981-99-4780-5_2</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/978-981-99-4780-5_2</pub-id></element-citation></ref><ref id="R174"><label>174</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sivandzade</surname><given-names>F</given-names></name><name name-style="western"><surname>Prasad</surname><given-names>S</given-names></name><name name-style="western"><surname>Bhalerao</surname><given-names>A</given-names></name><name name-style="western"><surname>Cucullo</surname><given-names>L</given-names></name></person-group><article-title>NRF2 and NF-&#1179;B interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches</article-title><source>Redox Biol</source><year>2019</year><volume>21</volume><fpage>101059</fpage><pub-id pub-id-type="doi">10.1016/j.redox.2018.11.017</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.redox.2018.11.017</pub-id><pub-id pub-id-type="pmcid">PMC6302038</pub-id><pub-id pub-id-type="pmid">30576920</pub-id></element-citation></ref><ref id="R175"><label>175</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sokolova</surname><given-names>O</given-names></name><name name-style="western"><surname>Naumann</surname><given-names>M</given-names></name></person-group><article-title>NF-&#954;B signaling in gastric cancer</article-title><source>Toxins (Basel)</source><year>2017</year><volume>9</volume><issue>4</issue><fpage>119</fpage><pub-id pub-id-type="doi">10.3390/toxins9040119</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/toxins9040119</pub-id><pub-id pub-id-type="pmid">28350359</pub-id><pub-id pub-id-type="pmcid">PMC5408193</pub-id></element-citation></ref><ref id="R176"><label>176</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sugano</surname><given-names>N</given-names></name><name name-style="western"><surname>Shimada</surname><given-names>K</given-names></name><name name-style="western"><surname>Ito</surname><given-names>K</given-names></name><name name-style="western"><surname>Murai</surname><given-names>S</given-names></name></person-group><article-title>Nicotine inhibits the production of inflammatory mediators in u937 cells through modulation of nuclear factor-kB activation</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>252</volume><issue>1</issue><fpage>25</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9599</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1006/bbrc.1998.9599</pub-id><pub-id pub-id-type="pmid">9813140</pub-id></element-citation></ref><ref id="R177"><label>177</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sun</surname><given-names>F</given-names></name><name name-style="western"><surname>Qu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J</given-names></name><name name-style="western"><surname>Burns</surname><given-names>TF</given-names></name><name name-style="western"><surname>Stabile</surname><given-names>LP</given-names></name><etal/></person-group><article-title>NF-&#954;B1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-&#954;B function</article-title><source>Oncogene</source><year>2016</year><volume>35</volume><fpage>2299</fpage><lpage>2310</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.299</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1038/onc.2015.299</pub-id><pub-id pub-id-type="pmid">26300007</pub-id><pub-id pub-id-type="pmcid">PMC4548811</pub-id></element-citation></ref><ref id="R178"><label>178</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sun</surname><given-names>SC</given-names></name></person-group><article-title>Non-canonical NF-&#954;B signaling pathway</article-title><source>Cell Res</source><year>2011</year><volume>21</volume><issue>1</issue><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/cr.2010.177</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1038/cr.2010.177</pub-id><pub-id pub-id-type="pmid">21173796</pub-id><pub-id pub-id-type="pmcid">PMC3193406</pub-id></element-citation></ref><ref id="R179"><label>179</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>W</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S</given-names></name><name name-style="western"><surname>Lyu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wei</surname><given-names>T</given-names></name><etal/></person-group><article-title>METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy</article-title><source>J Exp Clin Cancer Res</source><year>2023</year><volume>42</volume><issue>1</issue><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s13046-023-02638-9</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1186/s13046-023-02638-9</pub-id><pub-id pub-id-type="pmid">36932427</pub-id><pub-id pub-id-type="pmcid">PMC10022264</pub-id></element-citation></ref><ref id="R180"><label>180</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>M</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><etal/></person-group><article-title>From LncRNA to metastasis: The MALAT1-EMT axis in cancer progression</article-title><source>Pathol Res Pract</source><year>2024</year><volume>253</volume><fpage>154959</fpage><pub-id pub-id-type="doi">10.1016/j.prp.2023.154959</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.prp.2023.154959</pub-id><pub-id pub-id-type="pmid">38029713</pub-id></element-citation></ref><ref id="R181"><label>181</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Altamimi</surname><given-names>ASA</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Galangin as an inflammatory response modulator: An updated overview and therapeutic potential</article-title><source>Chem Biol Interact</source><year>2023</year><volume>378</volume><fpage>110482</fpage><pub-id pub-id-type="doi">10.1016/j.cbi.2023.110482</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cbi.2023.110482</pub-id><pub-id pub-id-type="pmid">37044286</pub-id></element-citation></ref><ref id="R182"><label>182</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Alfawaz Altamimi</surname><given-names>AS</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><etal/></person-group><article-title>New horizons in lung cancer management through ATR/CHK1 pathway modulation</article-title><source>Future Med Chem</source><year>2023</year><volume>15</volume><fpage>1807</fpage><lpage>1808</lpage><pub-id pub-id-type="doi">10.4155/fmc-2023-0164</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.4155/fmc-2023-0164</pub-id><pub-id pub-id-type="pmid">37877252</pub-id></element-citation></ref><ref id="R183"><label>183</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>G</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Unveiling the connection: long-chain non-coding RNAs and critical signaling pathways in breast cancer</article-title><source>Pathol Res Pract</source><year>2023</year><volume>249</volume><fpage>154736</fpage><pub-id pub-id-type="doi">10.1016/j.prp.2023.154736</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.prp.2023.154736</pub-id><pub-id pub-id-type="pmid">37579591</pub-id></element-citation></ref><ref id="R184"><label>184</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Ali</surname><given-names>H</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>O</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment</article-title><source>J Nanopart Res</source><year>2023</year><volume>25</volume><fpage>169</fpage><pub-id pub-id-type="doi">10.1007/s11051-023-05813-3</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s11051-023-05813-3</pub-id></element-citation></ref><ref id="R185"><label>185</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Subramaniyan</surname><given-names>V</given-names></name><etal/></person-group><article-title>Recent developments in the role of protocatechuic acid in neurodegenerative disorders</article-title><source>EXCLI J</source><year>2023</year><volume>22</volume><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.17179/excli2023-5940</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.17179/excli2023-5940</pub-id><pub-id pub-id-type="pmid">37636028</pub-id><pub-id pub-id-type="pmcid">PMC10450212</pub-id></element-citation></ref><ref id="R186"><label>186</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>AA</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><name name-style="western"><surname>Kazmi</surname><given-names>I</given-names></name><etal/></person-group><article-title>A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies</article-title><source>Int J Biol Macromol</source><year>2023</year><volume>253</volume><fpage>127375</fpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.127375</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.127375</pub-id><pub-id pub-id-type="pmid">37839597</pub-id></element-citation></ref><ref id="R187"><label>187</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Thapa</surname><given-names>R</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>G</given-names></name><name name-style="western"><surname>Dave</surname><given-names>P</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SK</given-names></name><name name-style="western"><surname>Raizaday</surname><given-names>A</given-names></name><name name-style="western"><surname>Almalki</surname><given-names>WH</given-names></name><etal/></person-group><article-title>Current update on the protective effect of epicatechin in neurodegenerative diseases</article-title><source>EXCLI J</source><year>2022</year><volume>21</volume><fpage>897</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.17179/excli2022-5034</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.17179/excli2022-5034</pub-id><pub-id pub-id-type="pmid">36172067</pub-id><pub-id pub-id-type="pmcid">PMC9489891</pub-id></element-citation></ref><ref id="R188"><label>188</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Tsurutani</surname><given-names>J</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>SS</given-names></name><name name-style="western"><surname>Brognard</surname><given-names>J</given-names></name><name name-style="western"><surname>Granville</surname><given-names>CA</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Gills</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells</article-title><source>Carcinogenesis</source><year>2005</year><volume>26</volume><fpage>1182</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgi072</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/carcin/bgi072</pub-id><pub-id pub-id-type="pmid">15790591</pub-id></element-citation></ref><ref id="R189"><label>189</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Valenca</surname><given-names>SS</given-names></name><name name-style="western"><surname>Castro</surname><given-names>P</given-names></name><name name-style="western"><surname>Pimenta</surname><given-names>WA</given-names></name><name name-style="western"><surname>Lanzetti</surname><given-names>M</given-names></name><name name-style="western"><surname>Silva</surname><given-names>SV</given-names></name><name name-style="western"><surname>Barja-Fidalgo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Light cigarette smoke-induced emphysema and NFkappaB activation in mouse lung</article-title><source>Int J Exp Pathol</source><year>2006</year><volume>87</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2613.2006.00492.x</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1111/j.1365-2613.2006.00492.x</pub-id><pub-id pub-id-type="pmid">16965565</pub-id><pub-id pub-id-type="pmcid">PMC2517381</pub-id></element-citation></ref><ref id="R190"><label>190</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Walter</surname><given-names>CEJ</given-names></name><name name-style="western"><surname>Durairajan</surname><given-names>S</given-names></name><name name-style="western"><surname>Periyandavan</surname><given-names>K</given-names></name><name name-style="western"><surname>C</surname><given-names>GPD</given-names></name><name name-style="western"><surname>G</surname><given-names>DJD</given-names></name><name name-style="western"><surname>A</surname><given-names>HRV</given-names></name><etal/></person-group><article-title>Bladder neoplasms and NF-&#954;B: an unfathomed association</article-title><source>Expert Rev Mol Diagn</source><year>2020</year><volume>20</volume><fpage>497</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1080/14737159.2020.1743688</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/14737159.2020.1743688</pub-id><pub-id pub-id-type="pmid">32228251</pub-id></element-citation></ref><ref id="R191"><label>191</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name></person-group><article-title>Atorvastatin might resist tobacco smoking-induced endothelial inflammation through the inhibition of NF-&#954;B signal pathway</article-title><source>Clin Exp Hypertens</source><year>2019</year><volume>41</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1080/10641963.2018.1433196</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1080/10641963.2018.1433196</pub-id><pub-id pub-id-type="pmid">29509049</pub-id></element-citation></ref><ref id="R192"><label>192</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L</given-names></name><name name-style="western"><surname>Jia</surname><given-names>B</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yao</surname><given-names>R</given-names></name><name name-style="western"><surname>N</surname><given-names>OU</given-names></name><etal/></person-group><article-title>Downregulation of m(6)A reader YTHDC2 promotes the proliferation and migration of malignant lung cells via CYLD/NF-&#954;B pathway</article-title><source>Int J Biol Sci</source><year>2021</year><volume>17</volume><fpage>2633</fpage><lpage>2651</lpage><pub-id pub-id-type="doi">10.7150/ijbs.58514</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.7150/ijbs.58514</pub-id><pub-id pub-id-type="pmid">34326699</pub-id><pub-id pub-id-type="pmcid">PMC8315025</pub-id></element-citation></ref><ref id="R193"><label>193</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tang</surname><given-names>H</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>An</surname><given-names>J</given-names></name></person-group><article-title>Association between sleep traits and lung cancer: a Mendelian randomization study</article-title><source>J Immunol Res</source><year>2021</year><volume>2021</volume><fpage>1893882</fpage><pub-id pub-id-type="doi">10.1155/2021/1893882</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1155/2021/1893882</pub-id><pub-id pub-id-type="pmid">34239941</pub-id><pub-id pub-id-type="pmcid">PMC8238591</pub-id></element-citation></ref><ref id="R194"><label>194</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wang</surname><given-names>JN</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Ke</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>CH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms</article-title><source>Sci Transl Med</source><year>2022</year><volume>14</volume><issue>640</issue><fpage>eabk2709</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.abk2709</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1126/scitranslmed.abk2709</pub-id><pub-id pub-id-type="pmid">35417191</pub-id></element-citation></ref><ref id="R195"><label>195</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wei</surname><given-names>TT</given-names></name><name name-style="western"><surname>Chandy</surname><given-names>M</given-names></name><name name-style="western"><surname>Nishiga</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>KK</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><etal/></person-group><article-title>Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation</article-title><source>Cell</source><year>2022</year><volume>185</volume><fpage>1676</fpage><lpage>1693</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.04.005</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2022.04.005</pub-id><pub-id pub-id-type="pmid">35489334</pub-id><pub-id pub-id-type="pmcid">PMC9400797</pub-id></element-citation></ref><ref id="R196"><label>196</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wibisana</surname><given-names>JN</given-names></name><name name-style="western"><surname>Okada</surname><given-names>M</given-names></name></person-group><article-title>Encoding and decoding NF-&#954;B nuclear dynamics</article-title><source>Curr Opin Cell Biol</source><year>2022</year><volume>77</volume><fpage>102103</fpage><pub-id pub-id-type="doi">10.1016/j.ceb.2022.102103</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.ceb.2022.102103</pub-id><pub-id pub-id-type="pmid">35636375</pub-id></element-citation></ref><ref id="R197"><label>197</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Williams</surname><given-names>LM</given-names></name><name name-style="western"><surname>Gilmore</surname><given-names>TD</given-names></name></person-group><article-title>Looking down on NF-&#954;B</article-title><source>Mol Cell Biol</source><month>14</month><year>2020</year><volume>40</volume><issue>15</issue><fpage>e00104</fpage><lpage>e00120</lpage><pub-id pub-id-type="doi">10.1128/MCB.00104-20</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1128/MCB.00104-20</pub-id><pub-id pub-id-type="pmid">32393609</pub-id><pub-id pub-id-type="pmcid">PMC7364044</pub-id></element-citation></ref><ref id="R198"><label>198</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wronka</surname><given-names>M</given-names></name><name name-style="western"><surname>Krzemi&#324;ska</surname><given-names>J</given-names></name><name name-style="western"><surname>M&#322;ynarska</surname><given-names>E</given-names></name><name name-style="western"><surname>Rysz</surname><given-names>J</given-names></name><name name-style="western"><surname>Franczyk</surname><given-names>B</given-names></name></person-group><article-title>The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><issue>24</issue><fpage>15743</fpage><pub-id pub-id-type="doi">10.3390/ijms232415743</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.3390/ijms232415743</pub-id><pub-id pub-id-type="pmid">36555387</pub-id><pub-id pub-id-type="pmcid">PMC9778895</pub-id></element-citation></ref><ref id="R199"><label>199</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Wu</surname><given-names>PP</given-names></name><name name-style="western"><surname>Liu</surname><given-names>KC</given-names></name><name name-style="western"><surname>Huang</surname><given-names>WW</given-names></name><name name-style="western"><surname>Chueh</surname><given-names>FS</given-names></name><name name-style="western"><surname>Ko</surname><given-names>YC</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>TH</given-names></name><etal/></person-group><article-title>Diallyl trisulfide (DATS) inhibits mouse colon tumor in mouse CT-26 cells allograft model in vivo</article-title><source>Phytomedicine</source><year>2011</year><volume>18</volume><fpage>672</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2011.01.006</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.phymed.2011.01.006</pub-id><pub-id pub-id-type="pmid">21315571</pub-id></element-citation></ref><ref id="R200"><label>200</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Xiong</surname><given-names>WM</given-names></name><name name-style="western"><surname>Xu</surname><given-names>QP</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>RD</given-names></name><name name-style="western"><surname>Hu</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Cai</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>F</given-names></name></person-group><article-title>Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China</article-title><source>Cancer Manag Res</source><year>2019</year><volume>11</volume><fpage>5785</fpage><lpage>5797</lpage><pub-id pub-id-type="doi">10.2147/cmar.S186217</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.2147/cmar.S186217</pub-id><pub-id pub-id-type="pmid">31388311</pub-id><pub-id pub-id-type="pmcid">PMC6607209</pub-id></element-citation></ref><ref id="R201"><label>201</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Quan</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wan</surname><given-names>H</given-names></name><etal/></person-group><article-title xml:lang="de"/><trans-title>Mechanisms of myeloid cell RelA/p65 in cigarette smoking-induced lung cancer growth in mice</trans-title><source>Zhonghua Zhong Liu Za Zhi</source><year>2014</year><volume>36</volume><fpage>412</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">25241781</pub-id></element-citation></ref><ref id="R202"><label>202</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>U</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Hou</surname><given-names>W</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name></person-group><article-title>Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>5467</fpage><lpage>5473</lpage><pub-id pub-id-type="doi">10.1007/s13277-015-4373-3</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1007/s13277-015-4373-3</pub-id><pub-id pub-id-type="pmid">26563375</pub-id></element-citation></ref><ref id="R203"><label>203</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Yin</surname><given-names>J</given-names></name><name name-style="western"><surname>Yin</surname><given-names>M</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>U</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yao</surname><given-names>T</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population</article-title><source>Gene</source><year>2015</year><volume>567</volume><issue>1</issue><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2015.04.059</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.gene.2015.04.059</pub-id><pub-id pub-id-type="pmid">25917613</pub-id></element-citation></ref><ref id="R204"><label>204</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Yun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>R</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name><name name-style="western"><surname>Sang</surname><given-names>N</given-names></name></person-group><article-title>Synergistic effects of particulate matter (PM10) and SO2 on human non-small cell lung cancer A549 via ROS-mediated NF-&#954;B activation</article-title><source>J Environ Sci</source><year>2015</year><volume>31</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.jes.2014.09.041</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.jes.2014.09.041</pub-id><pub-id pub-id-type="pmid">25968268</pub-id></element-citation></ref><ref id="R205"><label>205</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zago</surname><given-names>M</given-names></name><name name-style="western"><surname>Rico de Souza</surname><given-names>A</given-names></name><name name-style="western"><surname>Hecht</surname><given-names>E</given-names></name><name name-style="western"><surname>Rousseau</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamid</surname><given-names>Q</given-names></name><name name-style="western"><surname>Eidelman</surname><given-names>DH</given-names></name><etal/></person-group><article-title>The NF-&#954;B family member RelB regulates microRNA miR-146a to suppress cigarette smoke-induced COX-2 protein expression in lung fibroblasts</article-title><source>Toxicol Lett</source><year>2014</year><volume>226</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2014.01.020</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.toxlet.2014.01.020</pub-id><pub-id pub-id-type="pmid">24472607</pub-id></element-citation></ref><ref id="R206"><label>206</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zeng</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>CL</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>ZP</given-names></name><name name-style="western"><surname>Yu</surname><given-names>LH</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>XL</given-names></name><name name-style="western"><surname>Xie</surname><given-names>KQ</given-names></name></person-group><article-title>Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice</article-title><source>Toxicology</source><year>2008</year><volume>252</volume><issue>1-3</issue><fpage>86</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2008.07.062</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.tox.2008.07.062</pub-id><pub-id pub-id-type="pmid">18755235</pub-id></element-citation></ref><ref id="R207"><label>207</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Lenardo</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>30 Years of NF-&#954;B: a blossoming of relevance to human pathobiology</article-title><source>Cell</source><year>2017</year><volume>168</volume><issue>1-2</issue><fpage>37</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.12.012</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1016/j.cell.2016.12.012</pub-id><pub-id pub-id-type="pmid">28086098</pub-id><pub-id pub-id-type="pmcid">PMC5268070</pub-id></element-citation></ref><ref id="R208"><label>208</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name></person-group><article-title>Angiotensin-(1-7)-mediated Mas1 receptor/NF-&#954;B-p65 signaling is involved in a cigarette smoke-induced chronic obstructive pulmonary disease mouse model</article-title><source>Environ Toxicol</source><year>2018</year><volume>33</volume><issue>1</issue><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1002/tox.22454</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1002/tox.22454</pub-id><pub-id pub-id-type="pmid">28960804</pub-id></element-citation></ref><ref id="R209"><label>209</label><element-citation publication-type="journal"><person-group><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Luo</surname><given-names>F</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group><article-title>NF-&#954;B-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract</article-title><source>Toxicol Sci</source><year>2013</year><volume>135</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kft150</pub-id><comment>Available from: </comment><pub-id pub-id-type="doi">10.1093/toxsci/kft150</pub-id><pub-id pub-id-type="pmid">23824089</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><title>This table provides a concise summary of studies related to smoking-induced lung cancer, detailing various models, mechanisms, biological significance, key findings, and factors inducing changes in each study.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="EXCLI-23-991-t-001.jpg"/></fig><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><title>Graphical abstract</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="EXCLI-23-991-g-001.jpg"/></fig><fig position="float" id="F2" orientation="portrait"><label>Figure 2</label><caption><title>This image shows NF-&#954;B pathways, pivotal in immune responses. Toll-like receptors (TLR), T-cell receptors (TCR), and tumor necrosis factor receptors (TNFR) activate NF-&#954;B, influencing immune and inflammatory processes.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="EXCLI-23-991-g-002.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>Figure 3</label><caption><title>This image reveals that lung cancer-exposed cells express less YTHDC2, linked to smoking history and poor prognosis. YTHDC2 overexpression inhibits cancer <italic toggle="yes">in vivo</italic>, influenced by copy number deletion, and m6A alteration mediates its tumor-suppressive role via the CYLD/NF-&#954;B pathway. A vital connection is established between smoking-induced YTHDC2 downregulation and accelerated lung cancer development.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="EXCLI-23-991-g-003.jpg"/></fig><fig position="float" id="F4" orientation="portrait"><label>Figure 4</label><caption><title>The figure illustrates epigenetic mechanisms in cancer: Histone modifications lead to changes in gene expression and chromatin structure; DNA methylation loss results in aberrant transcription of target genes; Non-coding RNA regulation alters transcription and translation of oncogenic gene targets.</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="EXCLI-23-991-g-004.jpg"/></fig></floats-group></article></pmc-articleset>